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Cardiac catheterization procedures are classified as high radiation dose procedures, 
European Directive 2013/59/Euratom, and may result in skin injuries (deterministic 
effects) and/or increased cancer risk (stochastic effects). The radiation-induced 
effects can be expressed differently depending on whether the patient is a child or an 
adult. In adults there is an increased risk for developing radiation-induced skin 
injuries while in children the risk for radiation-induced cancer is more prominent. 
The cancer risk associated with radiation should be communicated to patients 
[directive 2013/59/Euratom], and patients with increased risk for skin injuries 
should be included in a follow-up program [ICRP 85]. However, skin dose and 
cancer risk estimates from cardiac interventional procedures are complicated 
because the dose indicator on the X-ray equipment only provides information on the 
total amount of radiation (air kerma-area product, KAP and cumulative air kerma at 
patient entrance reference point) used, without taking into account different radiation 
geometries. 
To facilitate monitoring of radiation induced effects, conversion coefficients that 
relate the radiation exposure as expressed by the air kerma-area product (KAP) to 
maximum entrance skin dose (MESD), equivalent organ dose (HT), effective dose 
(E), risk for exposure-induced cancer death (REID) and organ-specific risks of 
exposure-induced cancer death (REIDHT) have been estimated in the current thesis. 
Based on such coefficients, simple tools are suggested that can be used in the 
clinical routine with the aim to assess radiation doses and related risks. Two 
commercial software were used for the estimation of dose and related risks, 
WinODS (version 1.0a; RADOS Technology Oy, Finland) and PCXMC (v.1.5 and 
v.2.0; Radiation and Nuclear Safety Authority, Helsinki, Finland). In addition, film 
dosimetry techniques were been used for skin dose determination. 
The results from cohort studies on adult patients that underwent cardiac procedures 
showed that the skin dose (MESD) varies with both the type of cardiac procedure 
and with the skill of operator. On a patient-by-patient basis, the conversion 
coefficient relating KAP to skin dose can be used to identify patients with risk for 
radiation induced skin injury, to be included in follow up programs in accordance 
with ICRP 85. 
The relationship between E and KAP and between HT and KAP demonstrated a need 
for age- dependent conversion coefficients (E / KAP; HT / KAP) within the 
paediatric age range. Estimation of these quantities are performed using radiation 
exposure data retrieved from the patient radiation dose sheet as well as data from the 
complete radiation dose structured reports (RDSR); the latter contains detailed 
information on beam geometry and exposure data for the whole procedure. No 
significant difference between the two methodologies could be demonstrated for the 
population-averaged conversion coefficients (E / KAP; HT / KAP) except for HT 
(lung) in new-borns. The importance of this outcome is that hospitals that do not 
have access to the data retrieval and calculational methods used in this thesis (partly 
in-house development) can apply less detailed techniques without a significant effect 
on the estimated population dose, for a specific age group. 
Furthermore, the relationship between risk for exposure-induced cancer death 
(REID) and KAP displayed both age- and gender-dependence for paediatric cardiac 
catheterization procedures. The conversion coefficient (REID / KAP) can be used to 
assess the population cancer risk. In clinical situations, the estimated population 
cancer risk for the procedure can guide the operator in communicating risks to the 
patient/parent. Additionally, it has been shown that the risk organs for adult patients 
undergoing cardiac catheterizations are lung and bone marrow (leukemia), as well as 
for children lung and breast. 
The thesis introduces a novel concept based on age- and gender-specific risk 
reference values (RRV) that is related to a specific REID-level. By setting an 
“acceptable” level on the REID for a given patient group, the corresponding KAP 
value can be calculated and used for monitoring risk for late effects when 
performing cardiac intervention. 
In conclusion, cardiac catheterizations are life-saving procedures and thus the 
benefit is always considered to outweigh the risk. However, the ALARA principle 
(as low as reasonably achievable) must still be applied, which means that the patient 
must not be exposed to a higher radiation dose than is required for the procedure. 
Conversion coefficients presented in this dissertation can be a support for applying 
both the ALARA principle in clinical practice as well as for the identification of 
patients to be included in follow-up programs addressing skin injury and for 
communicating population cancer risk to patients. An additional intent of this thesis 
work has been to shed further light on important parameters that affect the radiation 
dose and risk, such as beam geometry (related to operator skill) and patient age and 




SUMMARY IN SWEDISH / SAMMANFATTNING PÅ 
SVENSKA 
 
Hjärtkateteriseringar definieras som högdosingrepp i EU direktivet 2013/59/Euratom 
och bedöms kunna orsaka strålningsrelaterade skador. Effekterna kan se olika ut 
beroende på om patienten är ett barn eller en vuxen. Vuxna har en ökad risk för 
hudskador (akuta skador) medan barn som är mer strålkänsliga än vuxna har högre 
risk för strålningsinducerad cancer (sena skador). Internationella strålskyddsorgan 
har tagit fram direktiv och rekommendationer för att följa upp patienter med 
strålningsinducerade akuta skador (ICRP 85) och även göra patienterna medvetna 
om de sena skadorna från strålningen via information som de ska få från vårdgivaren 
(direktiv 2013/59/Euratom).  
Hjärtkateterisering är ett ingrepp som utförs genom att föra in en kateter (tunn slang) 
i ett kärl via ljumsken eller armen samt spruta in kontrast samtidigt som man 
använder röntgenstrålning för att visualisera kärlen. Denna teknik används för att 
diagnostisera olika typer av hjärtfel och/eller behandla dem. Under senare tid har 
antalet ingrepp ökat pga att risken för medicinska komplikationer är mindre med 
denna teknik jämfört med öppen kirurgi.  Huddos- och cancerriskuppskattningar från 
hjärtkateteriseringar är emellertid komplicerade eftersom dosindikatorn på 
röntgenutrustningen endast ger information om den totala mängden strålning (air 
kerma-area produkten, KAP och luftkerma i patientens referenspunkt) som använts, 
utan att ta hänsyn till olika bestrålningsgeometrier.  
Fokus för denna avhandling var att analysera hur den totala strålningsmängden 
(KAP) förhåller sig till huddos (MESD, maximum entrance skin dose), ekvivalent 
organdos (HT), effektiv dos (E), cancerrisk (REID, risk for exposure-induced cancer 
death) och organspecifik cancerrisk (REIDHT, organ-specific risks of exposure-
induced cancer death) med syfte att tillhandahålla enkla verktyg att användas i den 
kliniska rutinen för att bedöma stråldoser och relaterade risker. De kommersiella 
mjukvaror som använts var WinODS (version 1.0a; RADOS Technology Oy, 
Finland) och PCXMC (v.1.5 och v.2.0; Radiation and Nuclear Safety Authority, 
Helsinki, Finland). Dessutom har filmdosimetriteknik använts för 
huddosbestämning. 
Resultaten från kohortstudier på vuxna patienter som genomgått hjärtprocedurer 
visade att huddosen (MESD) varierar med såväl procedur som operatör. För den 
enskilda patienten kan omvandlingskoefficienten som relaterar KAP till huddos 
användas inför beslut om uppföljning av eventuell hudskada i enlighet med ICRP 
85. 
Relationen mellan E och KAP och mellan HT och KAP har analyserats retrospektivt 
för patienter i olika åldersgrupper som genomgått hjärtprocedurer. Effekten av 
minskad strålkänslighet med stigande ålder kunde synliggöras genom 
omvandlingskoefficienterna (E/KAP; HT/KAP) som tydligt minskade med stigande 
ålder för den pediatriska gruppen. Förståelse för sambandet mellan dos och risk och 
dess variation med ålder är av speciell vikt för barn; detta för att ej underskatta 
risken för sena effekter hos de yngre patienterna. I dessa studier användes dels 
strålningsrelaterade data från patientens stråldosrapport, dels uppgifter från den 
fullständiga RDSR-rapporten; den senare innehåller detaljerad information om 
strålgeometri och exponeringsbetingelser för hela proceduren. En viktig slutsats var 
att den mer exakta metoden baserad på RDSR-data inte signifikant påverkade 
omvandlingskoefficienterna och att enklare metoder för beräkning av sådana 
koefficienter därmed kan användas (undantag av HT lunga för nyfödda). 
Vidare har förhållandet mellan risk för cancer (REID) och KAP analyserats 
retrospektivt för hjärtkateteriseringar. Resultaten visade att 
omvandlingskoefficienten för cancerrisk (REID/KAP) är både ålders- och 
könsberoende för den pediatriska gruppen. Denna omvandlingskoefficient kan 
användas vid bedömning av den populationscancerrisk som ingreppet innebär. I den 
kliniska situationen kan en skattad populationscancerrisk från användningen av 
strålning under ingreppet vara ett stöd för remittent/operatör när man ska informera 
om den risk som ingreppet innebär till patienten/föräldern. Information om 
strålningsrelaterade risker förutsätts vårdgivaren kunna ge enligt det europeiska 
direktivet 2013/59/Euratom. Studierna fastställde vidare att riskorganen för vuxna 
patienter som genomgår hjärtkateterisering är lunga och leukemi samt för barn lunga 
och bröst. 
En relativ hög andel, 7%, av alla hjärtkateteriseringar utförs på barn. För att hjälpa 
operatören att bevaka dos-/risk-nivåer till patienter av olika ålder och kön som 
genomgår hjärtkateteriseringar har ett nytt koncept introducerats för dessa 
förfaranden. Det nya konceptet baseras på ålders- och könsspecifika 
riskreferensvärden (RRV) som relateras till populationscancerrisken. Genom att 
ansätta en ”acceptabel” nivå för den strålningsrelaterade risken för en given 
patientgrupp kan motsvarande KAP-värde beräknas och användas som ett 
monitoreringsverktyg i klinisk rutin. 
Hjärtkateteriseringar är livräddande ingrepp och därmed bedöms nyttan alltid vara 
större än risken. ALARA-principen (as low as reasonably achievable) ska dock 
 
 
fortfarande tillämpas vilket innebär att patienten inte ska utsättas för högre stråldos 
än vad som krävs för ingreppet. Omvandlingskoefficienter som presenteras i denna 
avhandling kan vara ett stöd för att tillämpa såväl ALARA-principen i den kliniska 
verksamheten som inför beslut om uppföljning av patienter med möjliga hudskador 
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Ιn the past three decades, both incidence of and mortality from acute myocardial 
infarction have decreased dramatically in Sweden (Swedish National Board of 
Health and Welfare) [1]. This general trend in high income countries is reflected on 
in a paper by Dagenais et al [2], in which cancer is presented as the most common 
cause of death in middle-aged patients in countries with a high living standard. The 
positive development within cardiovascular disease has been promoted by effective 
preventive measures and by the introduction of catheter-based x-ray interventional 
techniques allowing for improved treatment outcomes. However, on a global scale 
cardiovascular disease still ends up as the major cause of death. 
The most common type of cardiovascular disease is coronary artery disease causing 
blocked or narrowed heart arteries. This is today treated with catheter-based x-ray 
interventional techniques [3]. The era of catheter-based cardiac treatment, 
angioplasty, started in 1977 and since then the number of interventional procedures 
has increased significantly [4-6]. In Sweden, around 2 million (approximately 20% 
of the population) suffer from cardiovascular disease, and about 45 000 coronary 
angiographies (CA) and 25 000 percutaneous coronary interventions (PCI), also 
referred to as percutaneous transluminal coronary angioplasty (PTCA), are 
performed yearly (Swedeheart annual report, 2019) [7]. The less invasive nature of 
interventional techniques compared to surgery is manifested in shortened 
hospitalization and improved quality of life.  
Cardiac interventional procedures are classified as high radiation dose procedures [8, 
9] with the main radiation induced side effect being skin injury (deterministic 
effect/tissue reaction; of main concern in adult patients) and increased cancer risk 
(stochastic effect; of main concern in paediatric and young adult patients). 
International radiation protection bodies have addressed these concerns by providing 
directives and recommendations in areas such as dose monitoring [8], risk 
communication [9] and follow-up of patients with skin injuries [10]. However, 
maximum entrance skin dose (MESD; given by the equivalent dose to the skin in 
this thesis) and risk for exposure-induced cancer death (REID) is complex to 
estimate since the dose indicator easily obtainable from the catheterization 
equipment, the air kerma-area product (KAP), only reports the total amount of 
radiation used during the procedure without taking into account the different 
irradiation projections used. The conditions inherent to catheterization procedures 
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call for reliable, yet fast, methods to estimate MESD and REID in the clinical 
setting. Such methods have not been available.  
This thesis addresses methods that can be applied to relate the KAP-value from an 
intervention to patient dose and related cancer risk with focus on cardiac treatments 
with catheter-based x-ray techniques. Both deterministic effects (here: skin dose, 
MESD) and stochastic effects (here: cancer risk, REID) have been investigated. The 
purpose has been to provide medical staff performing cardiac catheterizations with 
tools to address concerns related to the use of radiation on patient safety from such 
procedures. The work addresses specifically key factors that contribute to the 
uncertainty in the estimation of radiation dose and risk, such as patient age, gender, 
operator experience and irradiation geometry. 
The main method to estimate MESD has been film dosimetry whereas equivalent 
organ dose (HT), effective dose (E) and REID have been estimated through Monte 
Carlo (MC) simulations based on data from radiation dose structured reports 




Figure 1 summarizes the major events in the evolution of radiation protection 
relevant to interventional radiological techniques since the beginning of the 
interventional era. The contributions to the field from papers which are included in 
this thesis are presented in chronological order along this timeline.  
 
 
Figure 1 The evolution of radiation protection from the beginning of the cardiac 
interventional radiology era. 
Paper I: Patient data (adults); conversion coefficients for maximum entrance skin 
dose (MESD) for different cardiology procedures and different operators 
Paper II: Patient data (paediatric); age-dependent conversion coefficients for 
effective dose (E)   
Paper III: Patient data (paediatric); age-dependent conversion coefficients for 
equivalent organ dose (HT) and E  
Paper IV: Patient data (paediatric); age- and gender-dependent conversion 
coefficients for risk for exposure-induced cancer death (REID), age- and gender-
dependent conversion coefficients for organ-specific risks of exposure-induced 
cancer death (REIDHT) and age- and gender-dependent risk reference values (RRV)  








2.1 DOSE AND RISK IN INTERVENTIONAL RADIOLOGY– 
INTERNATIONAL PRACTICE WITHIN RADIOLOGICAL 
PROTECTION 
Interventional radiology (IR) refers to minimally invasive techniques that are used to 
diagnose and/or treat deeply situated structures by introducing a catheter through a 
tiny opening in the body and visualize its movement inside the body using x-ray 
imaging. The use of radiation can involve side effects referred to as either 
deterministic (acute effects) and/or stochastic (long term) effects. Deterministic 
effects, sometimes referred to as harmful tissue reactions in this thesis, can appear if 
the radiation dose reaches certain threshold levels. Stochastic effects (cancer), on the 
other hand are believed not to have any threshold and with a risk that increases with 
dose. Another important factor that needs to be taken into account is that the 
radiation sensitivity for deterministic and stochastic effects in a specific organ can 
differ between children and adults [9]. 
Deterministic effects 
At the dose levels used in IR, deterministic effects could appear in the skin, brain, 
eye lens and the heart. In their 2013 report UNSCEAR concluded that the paediatric 
brain (cognitive defects), eye lens (cataract) and heart (circulatory disease) appeared 
to be more radiation sensitive compared to adults [9]. The skin seemed, on the other 
hand, to be more resistant in children which could reflect a faster skin repair process 
in children compared to in adults.  
The most common type of harmful tissue reactions within IR are skin reactions [11] 
where the basal layer of the epidermis, being the second outermost layer of the 
epidermis, is at greatest risk [12]. Radiation skin reactions start with early transient 
erythema for skin doses >2 Gy (few hours after exposure) and is developed to main 
erythematous reactions for skin doses ~6 Gy (~10 days after exposure) and later, to 
dermal ischaemia for skin doses ~15 Gy (8-10 weeks after exposure). The threshold 






Current risk models are based on epidemiological data from the Japanese atomic 
bomb survivors in Hiroshima and Nagasaki (1945) taking into account the site of 
cancer, gender, age at exposure and attained age. The dose-effect relationship for 
stochastic effects are considered as being either linear (L), linear-quadratic (LQ) or 
quadratic (Q), depending on the specific organ. The Japanese epidemiological data is 
continuously updated, and existing dose effect estimates include cancer incidence 
and mortality data from this population until 1998 and 1987 (cancer incidence: 
BEIR VII, UNSCEAR 2006, ICRP 103 (solid cancer), [14]; ICRP 103 (leukemia) 
[15]) and until 2000 (cancer mortality: BEIR VII, UNSCEAR 2006, [16]). One of 
the organizations (ICRP) has stopped using mortality data and now includes only 
data for cancer incidence [13]. This is motivated by a considerably decline in 
mortality due to improved cancer treatments.  
While the dose effect at higher radiation doses can be modelled based on the 
outcome from the Japanese atomic bomb events, the relationship between low 
radiation dose and cancer induction continuous being a topic of much debate in the 
scientific community. More data will be needed to resolve this issue of great concern 
in a society that relies so heavily on medical diagnosis and treatments using 
radiation; interventional radiology included. As science progresses, updated models 
to determine the radiation induced cancer risk are being developed with the current 
ones published in BEIR VII [17], ICRP 103 [13], and UNSCEAR 2006 [18]. The 
general consensus is that children and young adults are more sensitive to stochastic 
effects of radiation than the elderly population. This is related to their larger 
proportion of dividing cells together with more years of post-exposure life (13, 17, 
19). At the same time, some contradictory views on this issue related to specific 
cancer sites exists as e.g. UNSCEAR 2013 [19] states that 10% of the cancer types 
observed in children show less sensitivity to radiation (e.g. lung) than adults and 
only 25% of the cancer types in children show a higher sensitivity (leukemia, 
thyroid, skin, breast and brain). 
In order not to overestimate the cancer risk at low dose and low dose-rate (< 100 
mSv, < 0.1 mGy/min, [20]) a dose and dose rate effectiveness factor (DDREF) was 
introduced in ICRP 60 [21].  Table 1 summarizes the variations on DDREF used by 
the different organizations. The variation reflects how the DDREF was derived, 
where UNSCEAR [18] base DDREF on life span study data, BEIR [17] on life span 
study and animal-data and ICRP [13] on human epidemiological studies (including 
life span study) and animal studies. 
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Yet another concern relates to the risk models, excess absolute risk (EAR) and 
excess relative risk (ERR), used to estimate radiation induced cancers across 
populations with different baseline cancer rates. To offset this transfer error, BEIR 
[17] and ICRP [13] use a weighted average of the EAR- and ERR-based risk 
estimates for each cancer site. UNSCEAR [18] have instead chosen to present the 
result from each model separately and at the same time expresses concern for the 
uncertainty involved with transferring risk across populations. 
The lifetime attributable risk (LAR) and the REID have been used to express the risk 
to a reference population (Euro-Americans in this thesis) over a lifetime to develop 
or die from radiation related cancer. The difference between these risk descriptors is 
the implementation of the survival function, where LAR refers to the survival 
function in an unexposed population and REID refers to the survival function in a 
population following exposure to radiation. At low dose, such as in diagnostic 
radiology, LAR and REID can be regarded as equal [22]. It should be noted that 
while ICRP [13] and BEIR [17] use LAR to express population risk, UNSCEAR 
[18] has chosen to use REID. 
The current recommendations of the different international organizations discussed 
here (UNSCEAR, ICRP, BEIR) on which model should be applied together with 
their respective data sources are summarized in table 1. Other models exist, such as 
the EPA from the U.S [23]. It uses the same basic model as BEIR VII [17] with 
some modifications. 
The radiation risk estimates presented in the papers included in this thesis are all 




Tabell 1 Comparison of the three cancer risk models, BEIR VII, UNSCEAR 2006 
and ICRP 103 
 BEIR VII UNSCEAR 2006 ICRP 103 
Epidemiological 




Solid cancer6: L2 
Leukemia: LQ1,2 
Solid cancer7: LQ1, L2 
with exception of skin 
and bone cancer 
Leukemia: LQ2  
Solid cancer8: L2  
Risk transfer 
model for lung 
and breast 
Lung: ERR/EAR - 
30%/70% 
Breast: EAR - 100% 
Doesn’t uses a hybrid 
ERR/EAR-model. Uses 
each model separately 
Lung: ERR/EAR - 
30%/70% 




American [China, Japan, Puerto 
Rico, UK, USA]3 
Euro-American4 
and Asian5  
DDREF 1.5 2 2 
L, linear; LQ, linear-quadratic; ERR, excess relative risk; EAR, excess absolute risk; 
DDREF, dose and dose rate effectiveness factor 
1mortality; 2morbidity; 3five populations separately; 4averaged over Sweden, UK and 
USA; 5averaged over Shanghai, Osaka, Hiroshima, Nagasaki; 6include stomach, 
colon, liver, lung, breast, prostate, ovary, bladder, thyroid, and others; 7not specified; 
8include thyroid, breast, esophagus, stomach, colon, liver, lung, ovary, bladder, and 
others. 
 
2.2 DOSE AND RISK DESCRIPTORS 
Estimation of risk from the use of radiation relies on a reasonably accurate dose 
estimate. While patient dose estimation in radiation therapy based on high energy 
external beam or brachytherapy techniques involves advanced and individualized 
dose planning since many years, diagnostic and interventional procedures have had 
to rely on much more crude and rudimentary approaches to estimate dose. Today, 
the access to detailed information on each irradiation event that forms part of a 
patient diagnostic/interventional procedure is slowly changing this and more 
sophisticated approaches to estimate dose can be attempted. 





A key quantity is the dose index PKA (also referred to as KAP). KAP has been used 
to obtain coefficients to convert a radiation exposure to dose or to risk for adverse 
radiation effects in groups of patients. 
The PKA is expressed as the product of air kerma free-in-air (Ka) and beam area 
(A=x*y) in a plane perpendicular to the beam axis [24]: 
𝑃𝑃KA =  ∫ 𝐾𝐾a  (𝑥𝑥,𝑦𝑦) 𝑑𝑑𝑥𝑥 𝑑𝑑𝑦𝑦
 
𝐴𝐴                                                                         (1) 
Harmful tissue reactions can appear following exposures exceeding a dose of 2 Gy 
to the skin [10]. The absorbed dose to the skin on the beam entrance side (D) is 
estimated according to equation 2 (IAEA TRS-457 [25]; Benmakhlouf et al [26]). 
D = Ka,i * Ba(Q, FS) * (µen(Q, FS)/ρ)w,a                                                    (2) 
where  Ba(Q, FS) = backscatter factor in air for beam quality Q and field size 
FS 
Ka,i = incident air kerma  
(µen(Q, FS)/ρ)w,a = mass-energy absorption ratio, water to air, for beam 
quality Q and field size FS 
Risk descriptors 
Estimating the risk of cancer induction in an exposed population relies on access to 
estimates of dose to the different organs of the body. The relation between HT (used 
to estimate stochastic effects of radiation) and mean absorbed dose is defined as 
[13]: 
𝐻𝐻𝑇𝑇 = � �𝐷𝐷𝑇𝑇,𝑅𝑅𝑤𝑤𝑅𝑅�
 
𝑅𝑅                                                        (3) 
where DT,R= mean absorbed dose in organ T from radiation of quality R 
wR = radiation weighting factor (wR=1 for x-rays) 
The radiation weighting factor accounts for variation in biological (detrimental) 
effect from different types of radiation. 
The effective dose (E) is a quantity that has been applied to provide gross risk 
estimates from the use of radiation for radiation protection purposes. Although it is 
not aimed for risk estimations in patients, it has been applied in communicating the 




𝐸𝐸 = ∑ (𝐻𝐻𝑇𝑇𝑤𝑤𝑇𝑇) 𝑇𝑇                                                                                           (4) 
where  HT = equivalent organ dose (organ T) for an adult reference person 
wT = tissue weighting factor (averaged over age- and gender) 
The tissue wT accounts for variation in radiation sensitivity between different 
tissues/organs. 
The lifetime risk quantity REID is used for population cancer risk estimations in this 
thesis, and is defined as the difference in mortality rate for exposed and unexposed 
populations of a given gender and a given age of exposure [27]: 
REID(e, HT) = ∫  
∞
𝑒𝑒+𝐿𝐿  [λ(a | e, HT) - λ(a)] S(a | e, HT) da                                (5) 
where L= latency time; L=5 years for solid cancers and L=2 years for 
leukemia 
a = attained age (years) 
e = age at exposure (years) 
HT = equivalent organ dose in organ T 
λ(a | e, HT) = λ(a) [1+ERR(a, e, HT)] or/and  
λ(a | e, HT) = λ(a) + EAR(a, e, HT) 
The λ(a | e, HT) is the cancer mortality rate at age a given that the person was 
exposed at the age e, the λ (a) is the background/baseline cancer mortality rate 
without radiation exposure. The survival function S(a | e, HT) denotes the probability 
that the person is alive at age a, given an equivalent organ dose HT at the age e. 
The lifetime risk quantity REID [27] has been slightly modified by the BEIR VII 
[17] committee through replacing the survival function S(a | e, HT) in equation 5 
with the S(a | e), the probability of an unexposed person to survive to age a, and 
renamed the REID to LAR. For x-ray diagnostic radiation doses, the REID and LAR 
can be considered almost identical [22]. LAR is also used in ICRP 103 [13]. 
Epidemiological data from exposed atomic bomb survivors in Hiroshima and 
Nagasaki (1945) is used to derive the two risk models, ERR and EAR. Each risk 
model is determined for solid cancer and leukemia and for cancer incidence and/or 
cancer mortality. Moreover, ERR and EAR are used to transfer the risk estimates 
from the Japanese atomic bomb survivors to a reference population (Euro-
Americans in this thesis) in terms of lifetime risk. 
The basic formula of the risk models (equation 6) is expressed as the product of the 
dose-response function F1(D) being linear (solid cancer), linear-quadratic (leukemia) 






including age at exposure, attained age and gender as variables. Equation 6 applies 
for risk models (ERR, EAR) used in BEIR VII [17], ICRP 103 [13] and UNSCEAR 
2006 [18]. 
ERR or EAR = F1(D) x F2(X)                                                     (6) 




   
𝐹𝐹2(𝑋𝑋) = 𝑒𝑒𝜃𝜃𝜃𝜃 
α, β, θ = fitting parameters, determined using epidemiological data from 
an exposed population. 
To obtain the best possible cancer risk transfer between epidemiological data and a 
reference population (Euro-Americans in this thesis), a weighted mean of ERR and 
EAR is adopted in BEIR VII. The weightings are 0.7/0.3 (ERR/EAR) for most solid 
cancers. For lung cancer the weightings are reversed and for breast- and thyroid 
cancers the EAR- and ERR-model are applied, respectively.  
For low dose and/or dose rate exposures, BEIR VII corrects the estimated risks for 
solid cancers by dividing the risk value obtained with a DDREF of 1.5. 
 
2.3 INTERVENTIONAL TECHNIQUES IN CARDIAC PROCEDURES 
 
 
1. X-ray tube 
2. Image receptor 
3. Patient couch 
 
Figure 2 Schematic image of a biplane angiography and interventional system 








Cardiac catheter-based angiography and interventional procedures are performed 
with dedicated x-ray systems which can be either monoplane (adult patients) or 
biplane (paediatric patients, fig. 2). The system uses predefined programs that allow 
for varying settings of parameters such as frame rate, air kerma rate, total tube 
filtration, and automatic dose rate control; the latter adjusts the beam quality to 
patient size and type of examination. Furthermore, different magnification modes 
can be chosen manually by the operator. Since 2010, all angiography and 
interventional x-ray systems produce DICOM Radiation Dose Structured Reports 
(RDSR) [28] that contain information on parameter settings from each irradiation 
event during the complete intervention. In addition, it is mandatory that the system 
provides information on the cumulative air kerma-area product, KAP, from the 
entire examination [8]. 
Interventional procedures are dynamic in that they use varying irradiation beam 
geometries and projections, beam qualities and dose rates. A single KAP-value is 
therefore not sufficient to determine whether the dose to a specific organ is high or 
not. Due to the complex nature of these examinations the KAP-value must therefore 
be accompanied with information on the type of catheter-based procedure. For 
patient risk estimations, information on the patient’s age and gender are essential. 
Cardiac catheterization procedures are minimally invasive and are performed by an 
interventionist (operator) who uses a catheter (thin, plastic tube) that is inserted into 
the blood vessel via the groin or arm and is then guided into the heart during 
radioscopy. In the next step, contrast dye is injected while radiation is used to 
visualize and detect blocked/narrowed heart arteries, a narrowed aortic valve and/or 
other cardiac pathologies. Blocked arteries are treated with angioplasty/percutaneous 
coronary intervention (PCI) procedures and consists of placing a stent to widen the 
artery. A calcified aortic valve is treated using the transcatheter aortic valve implant 
(TAVI) technique which involves replacing the valve with an implant taken from an 
animal (cow/pig). In paediatric patients with congenital cardiac disease, catheter-
based techniques are used to repair defects such as holes or narrowed arteries/valves. 
In children the use of magnification modes and higher frame rates is common due to 
the thinner vessels and higher heart rates observed in these patients. 
 
2.4 RADIATION RELATED RISKS IN INTERVENTIONAL CARDIOLOGY 
Since the introduction of catheter-based techniques to diagnose and treat heart 
conditions, radiation induced effects such as skin burns in adult patients and 
increased cancer risk in younger patients have been of concern. Figure 3 illustrates 
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how the two types of adverse radiation effects i.e. harmful skin reactions 











Figure 3 Deterministic effects with threshold values for some skin reactions (left 
panel; modified from ICRP 103) and stochastic effects in patients undergoing 
cardiac interventions; the latter illustrating the dependence on age and gender (right 
panel, data from paper IV and V). 
2.4.1 Deterministic effects in cardiac interventions 
Skin reactions occur when the radiation dose exceeds a specific threshold dose value 
(fig. 3, left panel). The severity of the skin reactions varies with dose in a typical s-
shaped manner [13]. High skin doses from interventional procedures could be 
expected after repeated or very complex procedures. In very rare situations dose 
levels like those given in fractionated radiotherapy have been reported [10]. In 
interventional cardiology the problem of high skin dose is reduced to adult patients. 
This is related to the relatively higher radiation exposure that is required to perform 
an intervention on the adult trunk compared to a much thinner paediatric patient. In 
addition, the skin of children is believed to be more resistant to radiation [19]. Thus, 
skin injuries from cardiac interventions are not a concern for this latter patient group 
[29-31]. 
Tissue reactions from heart procedures have been documented in the literature since 
the 1990s [32-38].  Despite the fast development and increased use of such 
techniques the reported occurrence of skin injuries or inflammatory skin reactions 
from such procedures continues to be rather low (1:10000-1:100000; [39]). This 
may to some extent be due to that the medical staff is not always aware of the risk 
for such injuries and will therefore not communicate this to the patient either. 
































Male, 80 years 
F mal , 15 years 
Male, 15 years 
Male, 1 years 
Tissue reactions          Skin dose 
                 (Gy) 
 Early transient reaction     2 
 Main erythema                  6 
 Dermal ischaemia            15 
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However, all patients undergoing IR procedures should be counselled on radiation 
related risks, before and after the IR procedure, and those with increased risk of 
radiation induced skin injuries should be followed up in accordance with the 
recommendations by ICRP 85 [10]. In addition, notes should be included in the 
patient record if MESD ≥ 1 Sv (equals 1 Gy in absorbed dose from x-rays) for 
procedures which might be repeated or if the cumulative MESD ≥ 3 Sv (or 3 Gy in 
absorbed dose from x-rays). The care-provider should provide a follow-up program 
for patients having reached a cumulative MESD of 3 Sv (or 3 Gy in absorbed dose) 
or higher.  
2.4.2 Stochastic effects in cardiac interventions 
Interventional radiology plays an important role in children suffering from 
congenital cardiac disease and, in recent years, the frequency of such procedures has 
increased [40]. Congenital heart disorders affect around 0.8% of the new-borns [41] 
and many of these children require complex medical treatment involving radiation. 
There are indications that E >50 mSv are associated with increased cancer risk [13, 
17]; such dose levels are not unusual in this patient group. Figure 3 (right panel) 
illustrates the dose-risk pattern for patients undergoing interventional cardiac 
procedures i.e. that the radiation related cancer risk at a given KAP-level is higher in 
younger patients than in elderly, and also higher in female compared to male 
patients. 
Children with congenital heart defects often undergo multiple examinations 
involving radiation [42-44], especially the very young ones [45]. This contributes to 
high cumulative organ doses and thus increased risk for cancer. Taking this into 
consideration, paediatric cardiac radiological interventions are still justified 
compared to alternative treatments using surgical intervention as the latter in general 
involves other, more severe, risks for the individual patient [9]. At the same time and 
due to a longer life expectancy in children compared to adults, it is of utmost 
importance to consider and, if possible, reduce any extra risk for adverse health 
effects in these patients. In order to achieve this, staff need to be well informed of 
the possible risks associated with paediatric interventions and also be acquainted and 
feel comfortable with how to communicate risks associated with radiation exposure 




3 METHODOLOGY TO ESTIMATE DOSE AND RISK FROM 
CARDIOLOGY INTERVENTIONS 
 
The Karolinska University Hospital is specialized in paediatric cardiac 
catheterization procedures and also performs a substantial number of 
catheterizations on adult patients. From a clinical perspective, there is a need to 
understand how the measured/estimated KAP-value from a cardiac catheterization 
procedure relates to risk for deterministic and stochastic effects for a given type of 
procedure and patient age/gender group. This requires estimates of the radiation 
dose delivered to different organs. 
The current work focuses on the estimation of the MESD, HT, E, REID, REIDHT and 
the associated conversion coefficients based on KAP from cardiac catheterization 
procedures in adult and paediatric patients. 
 
3.1 SKIN DOSE MONITORING 
Maximum entrance skin dose is not directly available from the DICOM/RDSR data 
pertaining to a specific patient procedure. The dose monitoring from the 
catheterization equipment instead only reports the total amount of radiation used 
during the complete procedure (KAP) and the cumulative air kerma at patient 
entrance reference point (15 cm from the isocenter in direction towards the x-ray 
tube [46]). A pragmatic approach to address this problem was suggested by the 
NCRP [47] and consists of implementing an overall action level for patient follow-
up of 500 Gycm2 (KAP), or 5 Gy in cumulative air kerma at the patient entrance 
reference point. 
In order to decrease the large uncertainties involved with the NCRP approach, 
several publications have reported alternative techniques for skin dose estimations. 
They include techniques based on measurements, such as using thermoluminescent 
dosimeters (TLD), films, real-time patient dosimeters, or on theoretical models [48-
58]. Common to all these techniques is, however, that they cannot easily be 
implemented in a clinical setting due to either complexity and/or cost. 
The last 7-8 years, dose mapping systems have become available: Dose Tracking 
System (Toshiba/Canon Medical Systems Corporation) [59], Dose Map (General 
Electric, Fairfiled, USA) [60], em.dose (esprimed SAS, Villejuif, France) [61]. They 
provide a skin dose map and a value of the maximum skin dose, either in real-time 
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(Dose Tracking System, Dose Map) or retrospectively (em.dose). A disadvantage is 
that these systems normally are restricted to be used with one specific 
manufacturer’s equipment (em.dose is system independent). A common method to 
validate dose mapping software is radiochromic film, which is also considered as the 
gold standard for entrance skin dose estimations.  
The question is what a film placed on the beam entrance side actually measures and 
how it relates to the dose to the skin? Looking at the different layers of the 
epidermis, its outermost layer is composed of dead skin and thereby not sensitive to 
radiation induced damage. The second layer, on the other hand, is indeed radiation 
sensitive and therefore of interest here. Given that the build-up region encountered 
in the energy range of diagnostic x-rays [62] can be equated with the thickness of the 
dead skin layer [63], the maximum dose is consequently deposited in the second 
outermost layer of the epidermis where the condition of charged particle equilibrium 
(CPE) exists. The effective point of measurement of the Gafchromic film XR-RV3 
(116.5 µm) used in this work is only slightly larger than the thickness of to the dead 
skin layer (~80 µm). We can therefore assume that CPE exists at the point of 
measurement and thereby the film dose equates the dose to the sensitive part of the 
epidermis. 
The MESD from film measurements is estimated using a calibration curve which 
converts the pixel values/optical density into absorbed dose (or entrance surface 
kerma) to air. This is followed by a calculation of the dose to water by applying the 
mass-energy absorption coefficient ratio (µen/ρ)w,air. It should be noted that in this 
thesis the calibration curves included the effect of backscatter that exists in the 
clinical situation with a patient being exposed. The (skin) dose for a specific beam 
quality based on the incident air kerma (Ka,i) at the film entrance level can be 
estimated using equation 2 [26]. 
In this work, Gafchromic film, slow radiographic films (EDR2, Kodak) and diode 
dosimeters (Unfors Patient Skin Dosemeter (PSD); Unfors Instruments, Billdal, 
Sweden) have been used to estimate skin dose.  
Based on estimated maximum skin doses, conversion coefficients correlating MESD 
with KAP for different types of cardiac procedures are presented. The impact of 
operator experience is addressed for the first time in paper I. The use of such 
coefficients as triggers for follow-up of patients at risk for radiation-induced skin 
injuries is suggested. 
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Other groups have reported conversion coefficients for MESD/KAP with results 
showing both good correlation between MESD and KAP [51, 64, 65], and poor 
correlation [66-68]. 
3.2 ESTIMATION OF ORGAN DOSE AND EFFECTIVE DOSE 
Effective dose is a convenient tool for simple relative cancer risk comparisons 
between different procedures and x-ray modalities. When more detailed cancer risk 
assessments are attempted, ICRP 103 [13] recommends the use of equivalent organ 
doses. A few papers have reported organ doses from paediatric cardiology 
procedures [31, 69-72]. 
Commonly applied methods for the estimation of organ- and effective dose in 
diagnostic radiology include the PCXMC v.2.0 software [73] (Radiation and 
Nuclear Safety Authority, Helsinki, Finland) or measurements using 
anthropomorphic phantoms with inserted dosimeters. 
One of the first programs to calculate organ dose from diagnostic radiology 
examinations was WinODS [74] (version 1.0a; RADOS Technology Oy, Finland). It 
was based on a size- and gender-adjustable phantom model and pre-calculated 
depth-dose distributions in a homogeneous water phantom. The program, a kind of 
pioneer in this field, was used in paper I and is a precursor to the software PCXMC. 
Dose calculations with PCXMC v.1.5 and v.2.0 [75, 73] are performed using the 
Monte Carlo (MC) technique to simulate radiation transport. It has been applied in 
this thesis to estimate dose and radiation risk from cardiac catheterizations in papers 
II-V. The mechanisms of interaction included in the MC simulations are photo-
electric absorption and Rayleigh- and Compton scattering. For beam energies used 
in interventional radiology, the secondary electrons in soft tissue are of such low 
energy that they can be treated as being absorbed at the site of the photon 
interaction, the only exception being in the bone marrow. 
In, PCXMC the dose to the active bone marrow (ABM) is assessed using a three-
factor technique by Lee C [76]. In this method, the ABM and the rest of the skeletal 
bone are treated as homogeneous bone tissue (HBT). The absorbed dose to the ABM 
is determined from the energy deposited in the HBT and applying correction factors 
that take into account 1) the fraction of ABM in the HBT area 2) the higher energy 
absorption in hard bone at low photon energies and 3) the increased absorbed dose 
by the photoelectrons as they enter the ABM from trabeculae.  
To calculate HT and E in PCXMC v.2.0, mathematical hermaphrodite phantom 
models of Cristy and Eckerman [77] are used with small modifications [73]. The 
phantoms model humans of different age and gender (newborn, 1- , 5- , 10- , 15-
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years old and adult).  Data on peak tube kilovoltage (kVp), thickness of beam total 
filtration, KAP-value, collimated beam size, beam position, focus-to-skin distance 
(FSD), irradiation geometry are used together with patient height, weight and age as 
input to the organ dose calculations. The program reports the mean absorbed dose 
averaged over the organ volume. 
As interventional procedures include multitudes of radiation events, detailed 
exposure data from RDSR can be used as input to the calculations in order to reduce 
the uncertainties of the organ dose estimates. In case RDSR data is not easily 
available, the patient radiation dose sheet that can be obtained from the x-ray system 
at the end of the procedure can be used. 
In this thesis work, E and/or HT have been estimated using three different 
approaches to account for the variation of beam geometry and radiation quality 
during the procedure: 
1. Using precalculated conversion coefficients for E (CCE:KAP=E/KAP) derived 
by Schmidt et al [78], combined with correction factors to adjust for different 
tube voltages and filtrations. With this approach, the main simplifications are 
related  to the irradiation geometry (fixed field sizes for each age group, fixed 
focus-skin distance) and to exposure-related data from the radioscopy part of 
the intervention (all radioscopy performed using only the frontal plane; 
anterior-posterior projection). These assumptions were needed as detailed 
information on the variation of these parameters during the intervention could 
not be retrieved from the patient radiation dose sheet. 
2. Using the dose calculation software PCXMC v.1.5 and v.2.0 [75, 73] 
/WinODS [74] together with exposure related data from patient radiation 
dose sheet. The same assumptions on the irradiation geometry as above are 
adopted. Further, due to lack of data in the patient radiation dose sheet, the 
KAP from all radioscopy irradiation is assumed to be delivered either from 
the anterior-posterior projection (study V) or equally distributed over the 
complete set of radiography images (study III). 
3. Using the software PCXMC v.2.0 [73] incorporated into an inhouse 
developed framework that perform automated dose calculations based on 
detailed patient beam data from RDSR files and data from the hospital 
information system (HIS) on patient height and weight [79]. This approach 
consists of three steps, where the first is to define the correlation between the 
patient’s anatomy and the projected x-ray beam. This is done using a so-
called target-centric approach that is based on  locating body anatomies using 
information on which position is most irradiated, i.e. the target. Next step 
 
 19 
takes into account the  absorption properties of the patient table in order to 
calculate a Ka,i on the location of the phantom model. The final step is to 
convert  the Ka,i  at beam entrance to HT using PCXMC v.2.0 [73]. 
 
3.3 ESTIMATION OF RISK FOR RADIATION INDUCED CANCER 
The effective dose, E, has long been used as an indicator of cancer risk [29, 40, 43, 
80, 81]. However, as this dose quantity (equation 4) is based on a “reference adult 
person”, the cancer incidence in patient groups with higher risk, such as children and 
female patients, is underestimated using this concept. In addition, the use of E in risk 
estimations is sensitive to changes in tissue weighting factors, wTs. To assess the 
radiation-induced cancer risk in different patient cohorts, the ICRP [13] commission 
instead suggests the use of the mean equivalent organ dose, HT (or mean absorbed 
(organ) dose). 
The E, HT, REID and REIDHT reported in this thesis are estimated using the software 
PCXMC v.1.5 and v.2.0 [75, 73]. All REID calculations were performed using 
version 2.0 of the software. The underlying risk module of PCXMC v.2.0 [73] is 
based on the risk models (ERR and EAR) from BEIR VII [17] and takes into 
account cancer site, gender, ethnicity, age at exposure and attained age. The lifetime 
risk quantity used in PCXMC v.2.0 [73] is the REID and not the simplified form of 
the lifetime risk LAR used by the BEIR VII [17] commission. For lifetime risk 
estimations, age-dependent mortality and cancer incidence rates for a Euro-
American population [13] were used in this work. 
In PCXMC v.2.0 the upper limit in the REID (infinity; equation 5) is replaced by 
120 years. PCXMC v.2.0 has by default a DDREF factor of 1.5 in solid cancers and 
1 for leukemia. For high organ doses (several tens or hundreds of mSv) PCXMC 
v.2.0 recommends a DDREF factor of 1 also for solid cancers, which must be 
corrected manually. 
To correlate the KAP-value to organ dose or cancer risk is not a trivial task in 
interventional cardiology due to the large variations in patient size and various types 
of cardiac procedures encountered. In addition, gender plays an important role in 
risk estimation and needs to be taken into account. 
In this thesis, conversion coefficients for equivalent organ dose 
(CCHT:KAP=HT/KAP), effective dose (CCE:KAP=E/KAP) and cancer risk 
(CCREIDHT:KAP=REIDHT/KAP; CCREID:KAP=REID/KAP) are presented for different 
patient age and gender.  
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It is to our knowledge the first-time methods are presented that relate KAP with 
organ dose and cancer risk in paediatric interventional cardiology. It is also the first 
time an automated approach based on complete patient RDSR data linked to a 




4 SCIENTIFIC QUESTIONS, STUDY DESIGN AND 
RESULTS 
 
The aim of this thesis has been to estimate radiation dose and associated risks from 
interventional cardiac radiology procedures performed on paediatric and adult 
patients using modern angiographic equipment. Such equipment provides the user 
with information on two dose-related metrics, the cumulative air kerma at patient 
entrance reference point [46] and/or the total KAP from the procedure. While the 
cumulative air kerma at patient entrance reference point can only be used in rough 
estimates of skin dose, the KAP provides a measure of the total amount of radiation 
used during the procedure and holds information that can be used to estimate dose to 
different organs and the risk for inducing cancer. In this thesis, the KAP-value plays 
a key role as the conversion coefficients for MESD, HT, E, REID and REIDHT are all 
expressed as a function of KAP. Access to such conversion coefficients allows for a 
direct estimation of levels of skin and organ doses to patients/group of patients 
undergoing this kind of procedures and thereby provide a link to risks for radiation 
induced deterministic and stochastic effects. They can be easily implemented in 
clinical routine work and used to trigger actions in areas such as follow-up of patient 
skin dose and operator training.  
The thesis includes 4 scientific questions related to dose and risk in interventional 
cardiology. A summary of these together with the intended clinical use of the results 
is presented in figure 4. Where tests of significance are applied, a significance level 
of α=0.05 was selected.  For some statistics, non-overlapping 95% confidence 
intervals have been used as a criterion for significance. Note that this criterion is 
simple to apply, but conservative (non-overlapping CIs unequivocally indicate 





Figure 4 Overview of the scientific questions and clinical use of the conversion 
coefficients: CCMESD:KAP = MESD/KAP, CCE:KAP = E/KAP, CCHT:KAP = HT/KAP, 
CCREID:KAP = REID/KAP, CCREIDHT:KAP = REIDHT/KAP. 
 
4.1 DETERMINISTIC EFFECTS IN CARDIAC PROCEDURES 
4.1.1 Outcome from question I [Studies I and V] 
Scientific question I 
Does the relation between patient skin dose (MESD) and total radiation exposure 
(KAP) vary with the type of cardiac procedure? 
Study design 
Study I was designed based on results from a pioneering work in the field performed 
at the Karolinska Hospital [58]. In the publication by Hansson [58], conversion 
coefficients (MESD/KAP) for different types of cardiac procedures (coronary 
angiography (CA), percutaneous coronary intervention (PCI)) were reported for the 
first-time. The work was based on measurements in anthropomorphic phantoms and 
the results indicated that the conversion coefficient for skin dose varied with the type 
of procedure. In studies I and V, the skin dose conversion coefficient and its 
dependence on procedure type is evaluated on patients undergoing CA, PTCA/PCI 
and TAVI. In both studies (I and V), the variation of patient skin dose and its 
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relationship to the amount of radiation used during the procedure, MESD/KAP, for 
different types of cardiac procedures (CA, PTCA/PCI, TAVI) are evaluated. All 
patient procedures were performed at the Karolinska University Hospital. 
The skin dose distribution and MESD were estimated using radiographic slow film 
combined with direct reading diode dosimeters (EDR2, Eastman Kodak Co., 
Rochester, NY; Unfors Patient Skin Dosimeter (PSD), Unfors Instruments, Billdal, 
Sweden; paper I) and self-developed radiochromic films (XR-RV3 Gafchromic film, 
International Specialty Products, Wayne, NJ, USA; paper V). The film calibrations 
in the two studies were based on the detector R100B (RTI Electronics AB, Mölndal, 
Sweden; calibrated in terms of air kerma) traceable through PTW (Germany) and 
diode dosemeters (Unfors Patient Skin Dosemeter (PSD); Unfors Instruments, 
Billdal, Sweden; calibrated for air kerma) for Gafchromic and EDR2 films, 
respectively. 
Results  
MESD and KAP for different types of cardiac procedures 
The MESD, KAP and corresponding conversion coefficient for skin dose 
(CCMESD:KAP= MESD/KAP) for CA, PTCA and TAVI procedures are presented in 
Table 2 (film measurements). The linear correlations of MESD versus KAP were 
regarded as acceptable (r = 0.8-0.97). 
Table 2 KAP (mean, range), MESD (mean, range), CCMESD:KAP (mean±1SD, 95% CI 
provided in square brackets) for patients undergoing CA (20 patients), PTCA (10 
patients) and TAVI (15 patients). 
Procedure type KAP (Gycm2) MESD (mSv) CCMESD:KAP (mSv/Gycm2) 
CA 49 (18-110) 410 (150-1300) 3.9±1.2 [3.3, 4.5] 
PTCA 40 (16-120) 410 (150-1300) 9.7±2.7 [7.8, 11.6] 
TAVI 29 (11-72) 290 (100-870) 9.7±1.5 [8.9, 10.5] 
KAP, air kerma-area product from the complete examination; MESD, maximum 
entrance skin dose; CCMESD:KAP, conversion coefficient for maximum entrance skin 
dose; SD, standard deviation; CI, confidence interval (calculated using the t-
distribution); CA, coronary angiography (diagnostic procedure); PTCA, 




The results based on diodes placed in the regions where the MESD was expected to 
be located showed a high failure rate with only 4 out of 20 (CA) and 1 out of 10 
(PTCA) successful measurements using this technique. 
Variation in irradiation technique used for different procedures 
Figure 5 (left panel) shows a typical skin dose distribution from a diagnostic 
procedure (CA), displaying the characteristic pattern with many projections and 
relatively few beam overlapping areas. As most CA procedures follow a standard 
irradiation technique, the skin dose distribution does not vary considerably between 
patients and in 90% of the patients included in this study, the MESD was positioned 
on the right-hand side of the patient’s back. Unlike CA, PTCA procedures are 
typically performed using fewer irradiation projections with more overlap of 
irradiated areas as can be seen in figure 5 (middle panel). In interventional 
procedures as PTCA, the dose distribution can differ significantly from patient to 
patient and will depend on the complexity of the procedure. The higher skin doses 
observed from such procedures are mostly located in regions of beam overlap 
between projections. 
The right panel in figure 5 shows a typical dose distribution map from TAVI 
procedures with few projections and frequent beam overlap. The skin dose 
distribution pattern for PTCA and TAVI results in similar CCMESD:KAP but from 
completely different dose distributions. 
 
  
Figure 5 Skin exposure mapping using film for a coronary angiography (CA; left 
panel; EDR2 Kodak), a percutaneous transluminal coronary angiography (PTCA; 
middle panel; EDR2 Kodak) and a transcatheter aortic valve implantation (TAVI; 
right panel; Gafchromic XR-RV3) procedure, respectively. Maximum entrance skin 
dose (MESD) was located on the right shoulder (Dx) for CA, on the left (Sin) side of 
the patient’s back for PTCA and on the middle of the patient’s back for TAVI. The 




Outcome and clinical implementation of the results 
The results verified that MESD and KAP vary with the type of cardiac procedure. 
The difference was pronounced when comparing diagnostic (CA) with 
interventional techniques (PTCA, TAVI) as the confidence intervals (table 2) do no 
overlap between them and this therefore calls for procedure-specific skin dose 
conversion coefficients, MESD/KAP. For patient follow-up of possible skin injury, 
alarm levels for transient skin erythema were estimated from the mean values of 
CCMESD:KAP in table 2 and for each procedure type. The defined alarm levels for 2 Sv 
in equivalent skin dose (or 2 Gy in absorbed dose) was set to 500 Gycm2 for CA and 
210 Gycm2 for PTCA and TAVI. 
4.1.2 Outcome from question II [Study I] 
Scientific question II 
Is the relation between patient skin dose (MESD) and total radiation exposure 
(KAP) for a given type of procedure operator dependent? 
Study design 
As demonstrated in figure 5 (in the previous section), cardiac angiography and 
interventional procedures do not follow the same irradiation pattern. This will 
influence the location of the MESD on the skin. In large university clinics having 
many operators there may be additional and significant variation in irradiation 
technique – for the same type of procedure - between the more experienced operator 
and those undergoing training. With experience comes skill and in the case of 
interventions, experienced operators are generally more aware of dose reduction 
techniques and the importance of irradiation geometry and may therefore, to a 
greater extent, avoid irradiation of the same skin area for a prolonged period of time.  
In study I the impact of operator experience on the patient skin dose was evaluated. 
The conversion coefficients for MESD were estimated for two operators, one with 
relatively short experience (2 years) while the second person was a senior operator 
with about 10 years of experience in performing this kind of procedures. The skin 
dose mapping was performed using slow radiographic films (EDR2, Eastman Kodak 
Co., Rochester, NY) combined with direct reading diode dosimeters (Unfors Patient 






Variation in beam projections between operators 
Figure 6 shows the result from film measurements of CAs procedures, performed by 
two operators with experience of 2 years (operator A, left panel) and 10 years 
(operator B, right panel), respectively. The skin dose maps between the two 
operators differ, and the operator with less experience tended to use more beam 
projections and less variation in projection angles between patients.  
   
Figure 6 Skin exposure maps (radiographic films) from two patients that underwent 
coronary angiography procedures, performed by two different operators (left panel, 




Variation in MESD/KAP between operators 
The relation between MESD and KAP for the two operators, which performed 10 
CA procedures each, are shown in figure 7.  
 
Figure 7 The median conversion coefficients (CCMESD:KAP) for the two operators was 
4.1 mSv/Gycm2 (operator A: 2 years of experience) and 3.4 mSv/Gycm2 (operator 
B: 10 years of experience), respectively. The boxes for each operator enclose 50% of 
the conversion coefficients for the 10 CA studies each operator performed. The 
maximum and minimum of the conversion coefficients corresponds to the endpoints 
of the bars. 
Outcome and clinical implementation of the results 
The results showed that MESD/KAP varies with operator experience, being 20% 
higher for the less experienced operator (operator A, fig. 7). Based on the results, 
alarm levels corresponding to 2 Sv in equivalent skin dose (or 2 Gy in absorbed 
dose) for CA and for each operator would correspond to 470 Gycm2 (CA; operator 
A) and 570 Gycm2 (CA, operator B). No test of statistical significance of the results 
was attempted before publication. However, the analysis was reconsidered when this 
thesis was written. Statistical significance between operators was tested for both 
CCMESD:KAP  and MESD using the Mann Whitney U-test. A clear difference between 
operators could be shown with regard to MESD, while the CCMESD:KAP did not 
display such difference. This demonstrates that the less experienced operator 
exposed the patients to higher KAP and thereby higher MESD, which is expected, 
but is not conclusive that there is a difference in the ratio MESD/KAP. 
Based on this outcome, a single conversion coefficient per procedure type is 
recommended to be used in the clinic. 
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4.2 STOCHASTIC EFFECTS IN CARDIAC PROCEDURES 
4.2.1 Outcome from question III [Studies I, II, III and V] 
Scientific question III 
Does the relation between effective dose (E) and air kerma-area product (KAP), and 
between equivalent organ dose (HT) and (KAP) vary with age and calculation 
method? 
Study design 
The first report on the dependence of E with KAP and with patient age in cardiac 
interventional procedures was published by Schmidt et al in 2000 [78]. The 
publication provides CCE:KAP for a range of projection angles, x-ray spectra and 
patient age groups. 
In our studies II, III and V, three different methods to take into account the 
irradiation geometry during the procedure are evaluated. In all studies, a single 
CCE:KAP is calculated for each procedure. The different study designs are 
summarized in figure 8. All three methods are based on MC simulations of radiation 
transport to calculate dose. Method 1 is the less accurate method and is based on 
precalculated CCE:KAPs [78] and method 3 is the most accurate as it uses all relevant 
exposure and geometric data from the RDSR file as input data to PCXMC v.2.0 
[73]. More detailed information on the assumptions applied for the different 
methods, is described in paragraph 3.2. (method 1, no 1; method 2, no 2, and method 
3, no 3).  
All three studies are retrospective cohort studies. Study II and III include 249 and 
202 paediatric patients, respectively, while study V is based on data from 22 adult 
patients. The studies were performed at the Karolinska University Hospital over a 
period of 17 years, in total. This means that x-ray systems based on different 
technologies were included (study II, image intensifier; studies III and V, flat panel 
detectors). During this period, the current ICRP data for tissue weighting factors 
(wT) were published. 
In summary, study II was based on methods 1 and 2 for the irradiation geometry and 
uses wT from ICRP 60, study III was based on methods 2 and 3 with wT from ICRP 




Figure 8 The three methods used to account for the irradiation geometry in patient 
cardiac interventions in estimations of conversion coefficients for effective dose 
(CCE:KAP) for each procedure. Method 1 is the less accurate technique while method 
3 is the most accurate.  
As given by the definition of E, it is calculated as a weighted sum of HT (equation 
3). This implies that if E depends on KAP [78] then HT should also depend on KAP. 
In study III the dependence of CCHT:KAP with age in cardiac catheterization 
procedures is estimated and reported for the first time in the literature. 
The dose to the lung (critical organ) is of special concern in cardiac interventions. 
The calculational efforts required for a reasonably robust prediction of lung dose is 
therefore of interest. The methodologies studied in this work (table 3) allow for 
some conclusions to be drawn in this respect. 
 Table 3 Methods to estimate conversion coefficients for organ dose (CCHT:KAP). 
Paper I WinODS [74] with input data from patient radiation dose sheets 
(method 2) 
Paper III PCXMC [73] with input data from 
patient radiation dose sheets 
(method 2) 
PCXMC [73] with input data from 
RDSR and HIS (method 3) 






Variation of E, HT and KAP with patient age using different methods to 
account for the irradiation geometry 
The results (fig. 9; mean value of conversion coefficients with 95% confidence 
interval (CI) using the t-distribution) showed a decrease in the conversion coefficient 
E/KAP (CCE:KAP; upper panel) and HT/KAP (CCHT:KAP for lung; lower panel) with 
increased patient age and with an indication of reaching a plateau around the age 
group of 15 years, for patients undergoing cardiac catheterizations. The average 
CCE:KAP- and CCHT:KAP results corresponding to the three (CCE:KAP) and two 
(CCHT:KAP) different methods to account for irradiation geometry are included. The 
impact of the new wT on the resulting CCE:KAP is demonstrated for method 2.  
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Figure 9 Upper panel: Conversion coefficient for effective dose (CCE:KAP ± 95% CI) 
as a function of age for patients undergoing cardiac procedures. The data include 
results from study II (tissue weighting factors (wT) from ICRP 60, method 1 and 2), 
study III (wT from ICRP 103, method 2 and method 3) and study V (wT from ICRP 
103, method 2). Lower panel: Conversion coefficient for lung equivalent dose 
(CCHT:KAP ± 95% CI) as a function of age. The data include results from study III 
(children; wT from ICRP 103, method 2 and method 3) and study I (adults; wT from 
ICRP 60, method 2). 
Outcome and clinical implementation of the results 
The results were conclusive in that there is indeed a clear dependence on age, in the 
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interventions. This is not unexpected as the organs in the youngest patients are 
situated very close to each other in this body region which makes it difficult to 
restrict the collimation of the beam only to the area of interest. This results in 
irradiation of larger proportion of individual organs and also of other, nearby organs, 
compared to in elderly patients. 
The average CCE:KAP results using different methods to account for irradiation 
geometry were very close to each other. Notably, for the two methods using the wT 
from ICRP 103, the CIs overlapped for each age group where they were calculated 
(figure 9).  
The results of paper III indicated no difference in mean convergence coefficient 
between method 2 and method 3 for both CCE:KAP and CCHT:KAP (lung). In the paper, 
however, the test was applied to all patients, without dividing into age groups. The 
results displayed in figure 9 are generally consistent with the conclusion on paper 
III. However, the stratification into age groups indicates a difference in CCHT:KAP 
(lung) for new-borns (clearly separated CIs). 
One important use of these results is to increase the awareness among clinical staff 
on the dose levels that are frequently encountered in cardiac procedures and that 
paediatric patients can receive doses, especially from the II-technology, that exceeds 
other x-ray imaging techniques. Table 4 below summarizes the results for E from 
cardiac procedures that have been estimated in this thesis work. For comparison, 
levels of typical E from abdominal adult CT examinations are indicated. As heart 
procedures in general are performed by staff trained in other specialties than 
radiology, special attention is needed to inform the staff of the patient doses 
involved so that relevant actions can be taken to monitor patient dose and to 




Table 4 Effective dose (mean, range) for different radiological examinations. 




E (mean; range) 
(mSv) 
CA1, 2 II >18 12; 4.1-24 
PTCA/PCI1, 2 II >18 12; 4.0-30 
TAVI3 FP >18 8.2; 2.6-21 
Paediatric cardiac catheterization2 II 0-18 9.3; 0.23-77 
Paediatric cardiac catheterization3 FP 0-18 2.1; 0.025-18 
Abdominal CT4  >16 7.6; 1.5-14 
1Effective dose (E) estimated using conversion coefficients from the paper by 
Hansson et al. [58]; 2wT from ICRP 60 [21]; 3wT from ICRP 103 [13]; II, image 
intensifier; FP, flat panel detector; 4National dose levels in Sweden, 2019; CA, 
coronary angiography (diagnostic procedure); PTCA, percutaneous transluminal 
coronary angiography; PCI, percutaneous coronary interventions; TAVI, 
transcatheter aortic valve implantation. 
4.2.2 Outcome from question IV [Studies IV and V] 
Scientific question IV 
Does the relation between risk of exposure-induced cancer death (REID) and air 
kerma-area product (KAP), and between organ-specific risk of exposure-induced 
cancer death (REIDHT) and KAP, vary with age and gender? 
Study design 
In studies IV and V the variation of the risk for stochastic effects from cardiac 
catheterization procedures with age, gender and KAP, are evaluated. 
The risk estimations are based on retrospective cohort studies and include 238 (study 
IV; newborn-18 years) and 22 (study V; 69-93 years) patients that had undergone 
different types of cardiac interventional and diagnostic procedures at the Karolinska 
University Hospital during the years 2013 to 2016. The REID and REIDHT were 
estimated using PCXMC v.2.0 [73]. 
Study IV is a continuation of study III and contains the first published data on 
conversion coefficients for risk of exposure-induced cancer death in patients 
undergoing cardiac interventions. Both organ specific coefficients, CCREIDHT:KAP, 
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and whole body coefficients, CCREID:KAP are reported. 
A novel risk surveillance tool – risk reference value (RRV) – related to the 
population cancer risk, is further introduced. The RRV for a given age and gender is 
given by the KAP-value corresponding to a REID of 0.1%. 
Study V focuses on the TAVI (transcatheter aortic valve implantation) procedure 
and reports conversion coefficients for REID and REIDHT in an elderly patient 
subgroup (>70 years). In addition, estimated lifetime risks for younger patients (40-
50 years) are reported. 
Results 
Dependence of the conversion coefficients for risk with age and gender  
Patients undergoing cardiac catheterization procedures at younger age are expected 
to suffer an increased risk for cancer at a given KAP compared to elderly patients 
due to their higher radiation sensitivity. In the same way, gender differences are 
expected. Figure 10 illustrates how the conversion coefficients for risk (CCREID:KAP, 
CCREIDHT:KAP, 95% CI, t-distribution; HT for lung) decrease with increasing age 
(newborn-90 years old) in the patient cohorts included in studies IV and V (cardiac 









Figure 10 Conversion coefficients for total risk (CCREID:KAP ± 95% CI) (left panel) 
and conversion coefficients for lung specific risk (CCREIDHT:KAP ± 95% CI) (right 





















































The contribution to the total REID from the different organs 
The organ specific risks REIDHT normalized to total REID for different age and 
gender groups are shown in figure 11. The top panel shows results for paediatric 
patients (newborns-18 years) while the lower panel includes data for adult patients 
(40-93 years). 
Although the data is consistent in that only cardiac procedures are included, it is 
clear that the relative contribution from different organs to the total risk differs 
between adults and children; the common denominator being that lung is the organ 
that contributes most to the risk for all ages (between 55% and 75%). In paediatric 
patients, the second highest contribution to the total REID is the breast (breast ca, 
females; (15-30) %), while the risk for leukaemia is the second highest contributor 
((15-30) %) in adults. Noteworthy is that the contribution from breast to the total 
cancer risk in adult female patients is considerably lower than in paediatric patients, 






Figure 11 The contribution to the total risk of exposure-induced cancer death 
(REID) from the risk of exposure induced cancer death for different organs 
(REIDHT). Top panel reports data for paediatric patients while the lower panel 
reports data for adults. Female (F); Male (M). 
Risk Reference Values (RRVs)  
The RRVs in table 5 correspond to a REID of 0.1%. About 90% of the patients 
included in study IV had a REID-value below 0.1%. The RRV increases with age 
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Table 5 Risk reference values (RRVs) corresponding to a REID of 1 in 1000 (0.1%) 







0 0.77 2.1 
1 1.5 4.3 
5 3.7 8.7 
10 6.5 15 
15 11 25 
REID, Risk for exposure-induced cancer death 
Outcome and clinical implementation of the results 
The results showed significant differences in risk conversion coefficients 
(CCREID:KAP, CCREIDHT:KAP) with age and gender for the paediatric patient group as 
the CIs didn’t overlap. Differences between the age groups 40 and 50 years, both 
female and male, were not clear for CCREID:KAP and CCREIDHT:KAP. Neither were 
differences between genders for the elderly patients (>70 years). In these cases, the 
CIs overlapped. 
Estimates of population cancer risk from the use of radiation in different kinds of 
medical procedures (here: cardiac interventional procedures) will help in the 
justification of a diagnostic and/or treatment procedure that involves the use of 
radiation. It can also be used to guide the responsible physician in communicating 
the risk involved to different groups of patients undergoing such procedures. The 
data on risks obtained from the studies IV and V are helpful for both these purposes. 
The cancer risk surveillance tool, RRV, provides the operator with an alert level 
that, if frequently reached, could call for a discussion of the need for improvements 
of irradiation techniques and optimization of machine settings. In our hospital a 
RRV-level that corresponds to a REID of 1 in 1000 has been implemented and is 






5 UNCERTAINTIES IN ESTIMATING PATIENT DOSE AND 
RISK IN CARDIAC X-RAY ANGIOGRAPHY AND 
INTERVENTION  
 
The uncertainty budget for film calibration (Gafchromic and EDR2 Kodak) 
comprises of uncertainties in dose, scanner or film processor and densitometer, and 
film. The uncertainty budgets for the two types of films are presented in table 6 and 
7. Although the number of measurements used to define the calibration curve also 
affects the uncertainty [82], this was not accounted for. The overall uncertainty for 
the Gafchromic film is at the same order as the level indicated by Farah et al. [82], 
commenting that an overall uncertainty of about 20% (k=1) is realistic within 
interventional radiology. 
The uncertainties in organ dose estimation with the MC code PCXMC v.2.0 are 
listed in table 8. The accuracy in the MC code used in PCXMC v.2.0 was evaluated 
in the paper by Borrego et al. [83] by comparing with the more elaborate MCNPX 
code [84]. The phantom model implemented in MCNPX code was an ORNL adult 
male phantom, which is almost the same mathematical phantom used in PCXMC 
v.2.0. Note that the total organ dose uncertainty estimated in table 8 assumes that the 
patient phantom is a perfect representation of patient anatomy. The effects due to 
mismatches between phantom and true organ geometry can certainly be expected to 
be large but is difficult to quantify and have not been included. 
The relative crudity of PCXMC’s stylized phantom compared to modern hybrid or 
voxelized phantoms is one source of anatomical mismatch, however it may not be 
the largest. In adult cardiac examinations, even when scaling for weight and height, 
the average mean absolute error in organ doses for a modern hybrid phantom 
compared to segmented CT scans has been estimated at still around 50% [85]. The 
average mean absolute error for a reference stylized phantom (ORNL phantom, not 
scaled for weight or height), however, was only 12% larger. This suggests, for 
cardiac examinations at least, the variation in organ size and location between 
patients of a similar size may be more significant for organ dose errors than the 
primitive geometrical definitions of stylized phantoms.  
The uncertainties presented in tables 6 to 8 are expressed for k=1 and the final 
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Table 8 Uncertainty in organ dose estimation using PCXMC v.2.0 code combined 














±8 Rectangular √3 4.6 Table V, 
Borrego et al. 
[83] 
PCXMC, 
statistical of MC 
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±1 Normal 1 ±1 This thesis 
X-ray field 
positioning 
±14 Rectangular √3 8.1 Table III, 
Omar et al. 
[79] 



















This thesis presents methods to monitor and evaluate the radiation dose and related 
risk to patients undergoing cardiac catheterization procedures. 
 
6.1 MONITORING AND ESTIMATION OF DETERMINISTIC EFFECTS OF 
RADIATION  
Skin injuries 
Built-in monitoring (KAP) of radiation dose in angiographic equipment was 
introduced in 1997 following requirements stated in the EURATOM directive 97/43 
[8]. Already three years later (2000) the International Commission on Radiological 
Protection, ICRP, published recommendations for counseling and follow-up of 
patients with risk for skin injuries from interventional procedures [10]. A skin dose 
level of 1 Gy per procedure in case of repeated interventions, and 3 Gy for a single 
intervention, were recommended as trigger levels for patient follow-up [10]. This 
illustrates how a technological development (built-in monitoring of a radiation dose-
related quantity) and recommendations for follow-up of adverse effects in patients 
need to be synchronized in order to facilitate compliance by the health care 
providers. 
In study I and V, the skin dose conversion coefficient (CCMESD:KAP) for CA, PCI and 
TAVI procedures were estimated (see table 9) and as expected, the CCMESD:KAP 
varied with the type of procedure (diagnostic- or interventional). Comparing our 
results with other publications, a variation in the CCMESD:KAP for a given type of 
procedure between hospitals is noted [table 9]. Differences in beam projection 
techniques between operators are believed to be important contributors to such 
variation, although the results of this thesis were unable to confirm this. Jarvinen H 
et al. [89] made similar conclusions by recommending hospital-specific values for 




Table 9 Mean CCMESD:KAP (mSv/Gycm2) for CA, PCI and TAVI 
Procedure type CA PCI TAVI 
This thesis1 4 10 10 
Järvinen J et al. [90]1   10 
Jarvinen H el al. [89]1  14  
Pasquino M et al. [91]1 3 7  
Kulkarni A R et al. [92]1 3 6  
Krajinovi´c M et al. [93]2  12  
Greffier J et al. [51]1 7   
CCMESD:KAP, conversion coefficient for maximum entrance skin dose; CA, coronary 
angiography; PCI, percutaneous coronary interventions; TAVI, transcatheter aortic 
valve implant; 1Film measurement; 2Calculated from Ka,i. 
Based on local estimates of CCMESD:KAP for various procedures, patients with 
increased risk for developing a skin injury can be identified. The choice of the 
limiting KAP-value used to find such patients should preferably take into account 
the variation of CCMESD:KAP between patients and between operators for the same 
type of procedure. In practice, there will always be a trade-off in cost-benefit when it 
comes to define a KAP alarm level. Selecting “too many” patients for follow-up 
(low alarm level) will be very costly without a clear benefit to many of the patients 
(false positive), while a high alarm level risk missing patients that have been 
affected (false negative). 
Film dosimetry continues to be the golden standard for accurate skin dose 
measurement from this kind of x-ray based procedures. At the same time, several 
software programs for monitoring skin dose distributions in real-time have been 
developed by manufacturers of angiography equipment. Given the complexity and 
time required to perform film dosimetry at large scale, software-based skin dose 
estimation has a clear role in a clinical setting. However, the validation of these 
softwares have not been performed in a structured way, which makes the 





Recently, radiation induced effects of the heart have received attention due to 
possible side effects and a threshold absorbed dose of 0.5 Gy to the heart related to 
the risk of circulatory disease has been presented [12]. Although heart disorders 
have not been specifically addressed in this thesis, it can be concluded that the 
threshold dose for circulatory disease has not been exceeded in the paediatric cohort 
in this work for single procedures (HT up to 60 mSv/procedure). The equivalent 
organ dose to the heart for adult patients is higher (HT up to 275 mSv/procedure, 
[95]) but still under the threshold dose for circulatory disease. However, as children 
are more sensitive than adults to radiation induced circulatory disease [19], 
awareness of this risk is advised. 
  
6.2 ESTIMATION OF STOCHASTIC EFFECTS OF RADIATION – 
CANCER INDUCTION 
Younger patients undergoing cardiac catheterization procedures are primarily 
exposed to other radiation related effects than adults. Given that younger persons 
have more radiation resistant skin combined with that the skin doses encountered are 
generally much lower than in adults, this is not an issue for this clientele. Instead the 
focus should be on radiation induced cancer. The risk for radiation induced cancer 
can be estimated using the dose metrics E or HT. In the 2007 ICRP report [13], the 
commission highlights the importance of using mean equivalent organ dose (or 
absorbed organ dose) as the basis for risk estimation. In practical terms, the use of E 
should be restricted to situations when different examination protocols and/or 
different equipment, are compared. 
In this thesis the concept of risk has been addressed by estimating conversion 
coefficients for HT and E in cardiac catheter-based procedures. The approach allows 
to link the KAP-values monitored by the x-ray angiography equipment to HT and to 
E. In the case of cardiac procedures, the breast poses special challenges and only 
presents a weak correlation to KAP in this work. This is most likely related to that 
the breast tissue is only partially irradiated during such procedures [96], thus causing 
also relatively small variations in beam angle to potentially have a significant impact 
on the mean dose to the breast. 
In the clinical context it is not possible to estimate organ dose from cardiac 
procedures in real-time on a patient-by patient basis and other ways to provide the 
operator with an indication of the radiation dose is needed. This thesis reports for the 
first time CCHT:KAP for paediatric cardiac catheterization procedures. This allows to 
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estimate organ doses directly from the registered KAP-value of the procedure. One 
important finding of the work is the clear dependence of age on the organ dose 
conversion coefficients, demonstrated by a CCHT:KAP for the lung that decreases with 
increased age within the paediatric age range.  
When it comes to the CCE:KAP,  the results presented in this thesis [paper II, paper IV, 
paper V] are within the same range as the CCE:KAP from the most recent publications 
in this area [69, 72, 95]. As reported in paper II, the dependence of irradiation 
geometry on CCE:KAP is of minor importance for patients in the same age group, 
resulting in similar conversion coefficients for different types of procedures. From 
this perspective, the CCE:KAP is more robust to technique variations than the organ 
dose conversion; all provided that the age dependence is properly accounted for. 
 
6.3 RISK COMMUNICATION 
Until now, communicating the increased risk for cancer from x-ray based cardiac 
procedures to patients/parents has been challenging as information connecting the 
exposure to risk has not been available to medical staff. Compliance to the directive 
2013/59/Euratom [9] has consequently been very poor. In this thesis, we present 
gender-specific and age-specific conversion coefficients (CCREID:KAP, CCREIDHT:KAP) 
for radiation induced cancer risk from cardiac procedures, starting from newborn 
and including the whole life span. The importance of gender on such risk is 
illustrated in the youngest age group where the CCREID:KAP is a factor of three higher 
in females than males. The higher carcinogenetic risk in female paediatric patients 
undergoing cardiac catheterizations is supported by results from Johnson et al. [44]. 
This reflects the gender difference in radiation sensitivity of lung [97] and breast 
tissue. 
Moreover, by combining the information in figures 10 and 11, an overall picture of 
the risk levels and the organs contributing to the risk for all age groups is given. As 
shown in this thesis and in other published papers [71, 80, 98], lung (female, male) 
and breast (female) are the organs contributing most to the risk in paediatric patients. 
In adult patients, the relative contribution to the risk for cancer induction from 
different organs looks somewhat different (figure 11). Lung remains an organ at risk 
[paper V, 95], followed by leukemia. This is the case both in adult females and 
males. The explanation for the increased risk for leukemia in adults is related to the 
different distribution of the active bone marrow in the human body at different age. 
In the youngest children the active bone marrow is concentrated to the skull and 
lower limbs while in adults it is concentrated to the chest, abdomen and pelvis [99]. 
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An understanding of which are the organs at risk at different patient age is 
fundamental to be able to perform optimization of the irradiation techniques and 
related machine settings. 
One of the aims of this thesis was to develop a surveillance tool - risk reference 
values (RRV) – that helps to monitor situations where the radiation dose exceeds a 
certain threshold risk level for a given patient. In our clinic we have implemented a 
RRV that corresponds to a REID of 0.1 %. This means that the operator will be 
alerted (by the integrated KAP-value) when the increased population risk for cancer 
induction reaches 0.1%. An important use of the RRV includes monitoring risk 
levels for different operators and how they develop with increased experience. This 
is expected to increase the operators’ awareness of how they can affect the risk for 







7 CONCLUSIONS AND REFLECTIONS ON THE NEED 
FOR FUTURE RESEARCH 
 
In this thesis, four clinically relevant scientific questions related to radiation dose 
and risk from x-ray cardiac procedures have been analyzed. The results have been 
used to develop tools to support clinical staff in complying with EC directives and 
international recommendations on radiation protection.  
The first and second scientific question (paper I and V) addressed conversion 
coefficients for skin dose from cardiac interventional procedures. A dependence 
with procedure type was demonstrated. The golden standard for skin dose 
estimations, film dosimetry, was used to estimate the dose. As film is not feasible to 
implement on a routine basis in the clinic, an alternative would be to use real-time 
skin dose monitoring software integrated into the angiography equipment. Some 
manufacturers provide such solutions for their own equipment. A platform that can 
be interfaced with any vendor’s equipment could be an alternative choice and, 
maybe, the ultimate choice if skin dose monitoring is to be implemented on a large 
scale. Such softwares are available [94] but with limitations in the accuracy.  
The third scientific question (paper I, II, III and V) was formulated with the aim to 
estimate the relations between E and KAP, and between HT and KAP for different 
patient age. A clear dependence on age was found within the paediatric age range 
regardless whether using procedure specific data from RDSR (paper III) or data 
from patient radiation dose sheets (paper I, III) or a simplified method based on 
predetermined conversion coefficients (paper II). Further, no significant difference 
between the different calculation methodologies could be demonstrated for the 
population-averaged conversion coefficients, except in an isolated case (lung HT, 
newborns). The use of voxelized phantoms instead of mathematical phantoms used 
in our work could possibly minimize the errors in the HT and E estimations. The 
effect on the conversion coefficients is unclear and would need further work to 
evaluate. 
Organ dose conversion coefficients are of special interest when performing 
epidemiological studies. By collecting KAP-values from patient cohorts that have 
undergone examinations/interventions, the conversion coefficients allow for a link 
between organ doses and late effects to be established. Future research includes to 
estimate the radiation doses for large patient cohorts and to correlate the findings 
with cancer registers in Sweden. This work is in the planning stage.  
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Conversion coefficients for cancer risk (CCREID:KAP, CCREIDHT:KAP) were addressed in 
paper IV and V (fourth scientific question), demonstrating both an age- and gender-
dependence within the paediatric age range of these coefficients. Even though the 
same body area is exposed to radiation in both paediatric and adult patients 
undergoing cardiac catheterization, it is important to recognize that the organs 
contributing most to the risk differs between them (paediatric patients: lung and 
(female) breast; adults: lung and active bone marrow). The knowledge gained in 
these studies provides the operator with information that will help in the 
communication of radiation risks from cardiac procedures to patients/parents. 
Until now, there has been a lack of a risk surveillance tool that considers age and 
gender in x-ray based paediatric cardiac catheterization. A novel concept based on 
the cancer risk (risk reference value, RRV) has been introduced in this thesis. It is 
suggested as a tool to monitor typical risk levels from cardiac procedures and as an 
educational tool during operator training.  
In conclusion, this thesis increases the knowledge of radiation induced side effects 
within cardiac interventional radiology. The work encompasses the entire life span 
in both female and male patients. The suggested tools facilitate the follow-up of 
patients with risk for radiation induced skin injuries [10], in risk communication 
with patients/parents [9] and in monitoring of dose/risk levels (RRV). All of these 
can be used to better understand and, to some extent, limit radiation-induced effects 





First and foremost, I would like to express my sincere gratitude to my main 
supervisor Associate Professor Annette Fransson for her excellent guidance and 
support during the process that led to a doctoral thesis. I would like to thank you for 
the academic support you gave me, your understanding and empathy. 
I am particularly grateful to my co-supervisor Gavin Poludniowski who generously 
imparted his knowledge and expertise in this thesis. Gavin, thank you for your 
support and guidance, it made it way easier to achieve my goal. 
I wish to send my appreciation to Birgitta Hansson for introducing me in the area of 
interventional radiology and my mentor Cathrine Jonsson as well. 
Thanks to all my colleagues who helped me throughout this journey. I am 
particularly grateful to Shahla Mobini and Jan Lindström for motivated me to 
continue when the road got tough. In addition, the “angiography-group” Artur Omar 
and Markus Hulthén for the stimulating physics discussions, and Jörgen Scherp 
Nilsson for sharing his knowledge on how to present images on an aesthetic way. 
Furthermore, a big thank to all colleagues at the department of cardiology, 
department of pediatric cardiology and department of pediatric radiology at 
Karolinska University Hospital. 
Last but not least, I would like to express my gratitude towards my family for the 
encouragement that helped me complete this dissertation. Thank you, Konstantinos 
and Leandros for understanding that the vacations in Greece with mom not only 










2. Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, 
hospital admissions, and deaths in middle-aged adults in 21 countries from 
five continents (PURE): a prospective cohort study [published correction 
appears in Lancet. 2020 Mar 7;395(10226):784]. Lancet. 
2020;395(10226):785-794. doi:10.1016/S0140-6736(19)32007-0. 
3. Wijns W, Kolh P, Danchin N, et al., Guidelines on myocardial 
revascularization: The Task Force on Myocardial Revascularization of the 
European Society of Cardiology (ESC) and the European Association for 
Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31:2501–55. 
4. Fokkema, M. L. et al. Population trends in percutaneous coronary 
intervention: 20-year results from the SCAAR (Swedish coronary 
angiography and angioplasty registry). J. Am. Coll. Cardiol. 61, 1222–1230 
(2013). 
5. Samara, E. T, Aroua, A, Bochud, F. O, Ott, B, Theiler, T, Treier, R, Trueb, P. 
R., Vader, J. P., Verdun, F. R. Exposure of the Swiss population by medical 
x-rays: 2008 review. Health Phys. 102, 263–70 (2012). 
6. Picano, E., Santoro, G. and Vano, E. Sustainability in the cardiac cath lab. 
Int. J. Cardiovasc. Imaging. 23, 143–147 (2007). 
7. https://www.ucr.uu.se/swedeheart/dokument-sh/arsrapporter-sh/1-
swedeheart-annual-report-2019/viewdocument/2948. 
8. European Community Council Directive 97/43/Euratom of 30 June 1997 on 
health protection of individuals against the dangers of ionizing radiation in 
relation to medical exposure. Official J. European Commun. L180, 0022–
0027 (1997). 
9. European Council Directive 2013/59/Euratom on basic safety standards for 
protection against the dangers arising from exposure to ionising radiation and 
repealing Directives 89/618/Euratom, 90/641/Euratom, 96/29/Euratom, 
97/43/ Euratom and 2003/122/Euratom. OJ of the EU. L13; 57: 1-73. 
10. ICRP, 2000. Avoidance of Radiation Injuries from Medical Interventional 
Procedures. ICRP Publication 85. Ann. ICRP 30 (2). 
11. Wunderle K, Gill S. A. Radiation-Related Injuries and Their Management: 
An Update. Semin Intervent Radiol 2015;32:156–162. 
 
54 
12. ICRP, 2012 ICRP Statement on Tissue Reactions / Early and Late Effects of 
Radiation in Normal Tissues and Organs – Threshold Doses for Tissue 
Reactions in a Radiation Protection Context. ICRP Publication 118. Ann. 
ICRP 41(1/2). 
13. ICRP, 2007. The 2007 Recommendations of the International Commission on 
Radiological Protection. ICRP Publication 103. Ann. ICRP 37(2–4). 
14. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K, 
Kodama K. Solid cancer incidence in atomic bomb survivors: 1958–1998. 
Radiat. Res. 2007;168:1–64. 
15. Preston DL, et al. Cancer incidence in atomic bomb survivors. Part III: 
Leukemia, Lymphoma and Multiple Myeloma, 1950–1987. Radiat. Res. 
1994;137:S68-S97. 
16. Preston DL, Pierce DA, Shimizu Y, Cullings HM, Fujita S, Funamoto S, 
Kodama K. Effect of recent changes in atomic bomb survivor dosimetry on 
cancer mortality risk estimates. Radiat. Res. 2004;162:377-389. 
17. National Research Council of the National Academies. Health risks from 
exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington, 
DC: National Academies Press; 2006. 
18. United Nations Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR) 2006 UNSCEAR 2006 Report—Effects of Ionizing Radiation 
Annex A: United Nations (New York: United Nations). 
19. UNSCEAR (2013) Sources, effects and risks of ionizing radiation, United 
Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR 
2013 Report to the General Assembly, with Scientific Annexes, 
http://www.unscear.org/unscear/en/pub lications/2013_1.html 
20. UNSCEAR (2012) United Nations Scientific Committee on the Effects of 
Atomic Radiation UNSCEAR 2012 Report to the General Assembly, with 
Scientific Annexes, http://www.unscear. 
org/unscear/en/publications/2012.html 
21. ICRP, 1991. 1990 Recommendations of the International Commission on 
Radiological Protection. ICRP Publication 60. Ann. ICRP 21 (1-3). 
22. Kellerer AM, Nekolla EA, Walsh L. On the conversion of solid cancer excess 
relative risk into lifetime attributable risk. Radiat Environ Biophys. 
2001;40(4):249-257.  
23. U.S. Environmental Protection Agency. EPA radiogenic cancer risk models 




24. ICRU, 2005. International Commission on Radiation Units and 
Measurements. Patient dosimetry for X rays used in medical imaging. Journal 
of the ICRU Report 74. 
25. INTERNATIONAL ATOMIC ENERGY AGENCY, Dosimetry in 
Diagnostic Radiology: An International Code of Practice, Technical Reports 
Series No. 457, IAEA, Vienna (2007). 
26. Benmakhlouf H, Bouchard H, Fransson A, Andreo P. Backscatter factors and 
mass energy-absorption coefficient ratios for diagnostic radiology dosimetry. 
Phys Med Biol. 2011;56(22):7179-7204. doi:10.1088/0031-9155/56/22/012 
27. Thomas D, Darby S, Fagnani F, Hubert P, Vaeth M and Weiss K. Definition 
and estimation of lifetime detriment from radiation exposures: Principles and 
methods. Health Physics 1992;63(3): 259-272. 
28. IEC, 2010 Medical Electrical Equipment—part 2-43: Particular Requirements 
for the Safety of X-Ray Equipment for Interventional Procedures vol 60601, 
2nd edn (Geneva: International Electrotechnical Commission). 
29. Song S, Liu C, Zhang M. Radiation dose and mortality risk to children 
undergoing therapeutic interventional cardiology. Acta Radiol 
2015;56(7):867e72. 
30. Yakoumakis EN, Gialousis GI, Papadopoulou D, et al. Estimation of 
children's radiation dose from cardiac catheterisations, performed for the 
diagnosis or the treatment of a congenital heart disease using TLD dosimetry 
and Monte Carlo simulation. J Radiol Prot. 2009;29(2):251-261. 
doi:10.1088/0952-4746/29/2/011. 
31. Kawasaki T, Fujii K, Akahane K. Estimation of Organ and Effective Doses 
for Neonate and Infant Diagnostic Cardiac Catheterizations. AJR Am J 
Roentgenol. 2015 Sep;205(3):599-603. 
32. FDA, 1994. Avoidance of serious x-ray-induced skin injuries to patients 
during fluoroscopically-guided procedures. Statement 9 Sept. 1994, Food and 
Drug Administration, Rockville, MD, USA. 
33. Lichtenstein D. A, Klapholz L, Vardy D. A, Leichter I, Mosseri M, Klaus S. 
N and Gilead L. T. Chronic radiodermatitis following cardiac catheterization. 
Arch. Dermatol. 132, 663–667 (1996). 
34. Sovik, E., Klow, N. E., Hellesnes, J. and Lykke, J. Radiation-induced skin 
injuries after percutaneous transluminal coronary angioplasty. Acta Radiol. 
37, 305–306 (1996). 
35. Barnea Y, Amir A, Shafir R, Weiss J, Gur E. Chronic radiodermatitis injury 




36. Aerts A, Decraene T, van den Oord JJ, Dens J, Janssens S, Guelinckx P, et al. 
Chronic radiodermatitis following percutaneous coronary interventions: a 
report of two cases. J Eur Acad Dermatol Venereol. 2003; 17(3):340–343. 
PMID: 12702082 
37. Banaag LdeO, Carter MJ. Radionecrosis induced by cardiac imaging 
procedures: a case study of a 66-year-old diabetic male with several 
comorbidities. J Invasive Cardiol. 2008; 20(8): E233–236. PMID: 18688069 
38. Garcia Reitbock J, Feldmann R, Ruhringer K, Breier F, Steiner A. Chronic 
radiodermatitis following percutaneous transluminal coronary angioplasty. J 
Dtsch Dermatol Ges. 2013; 11(3): 265–266. doi: 10.1111/ddg.12004 PMID: 
23279977. 
39. Tsapaki V, Rehani MM. I perform more than 100 interventional procedures 
every year but have never seen radiation-induced skin injury: am I missing 
something?. AJR Am J Roentgenol. 2014;203(5):W462-W463. 
doi:10.2214/AJR.13.11765. 
40. El Sayed MH, Roushdy AM, El Farghaly H, El Sherbini A. Radiation 
exposure in children during the current era of pediatric cardiac intervention. 
Pediatr Cardiol 2012;33(1):27-35. 
41. Marelli AJ, Mackie AS, Ionescu-Ittu R, et al. Congenital heart disease in the 
general population: changing prevalence and age distribution. Circulation 
2007;115:163–172. 
42. Beausejour Ladouceur V, Lawler PR, Gurvitz M, Pilote L, Eisenberg MJ, 
Ionescu-Ittu R, et al. Exposure to low-dose ionizing radiation from cardiac 
procedures in patients with congenital heart disease: 15-year data from a 
population-based longitudinal cohort. Circulation. 2016;133:12–20. 
43. Ait-Ali L, Andreassi M, Foffa I, Spadoni I, Vano E, Picano E. Cumulative 
patient effective dose and acute radiation-induce chromosomal DNA damage 
in children with congenital heart disease. Heart (British Cardiac Society). 
2010;96:269–74. 
44. Johnson JN, Hornik CP, Li JS, Benjamin DK Jr, Yoshizumi TT, Reiman RE, 
et al. Cumulative radiation exposure and cancer risk estimation in children 
with heart disease. Circulation. 2014;130:161–7. 
45. Justino H 2006 The ALARA concept in pediatric cardiac catheterization: 
techniques and tactics for managing radiation dose Pediatr. Radiol. 36 146–
53. 
46. IEC, 2009 Medical electrical equipment - Part 2-54: Particular requirements 
for the basic safety and essential performance of X-ray equipment for 




47. NCRP, Report 168: Radiation dose management for fluoroscopically-guided 
interventional procedures, NCRP Report No.168 (2010). 
48. Bogaert E, Bacher K, Lemmens K, Carlier M, Desmet W, De Wagter X, et al. 
A large-scale multicentre study of patient skin doses in interventional 
cardiology: dose-area product action levels and dose reference levels. Br J 
Radiol 2009;82:303–12. 
49. Bor D, Olgar T, Toklu T, Caglan A, Onal E, Padovani R. Patient doses and 
dosimetric evaluations in interventional cardiology. Phys Med 2009;25:31–
42.  
50. Bordier C, Klausz R, Desponds L. Patient dose map indications on 
interventional X-ray systems and validation with Gafchromic XR-RV3 film. 
Radiat Prot Dosim 2015;163:306–18. 
51. Greffier J, Moliner G, Pereira F, Cornillet L, Ledermann B, Schmutz L, 
Lomma M, Cayla G, Beregi JP. Assessment of Patient's Peak Skin Dose 
Using Gafchromic Films During Interventional Cardiology Procedures: 
Routine Experience Feedback. Radiat Prot Dosimetry. 2017 Apr 
28;174(3):395-405. 
52. Jones AK, Pasciak AS. Calculating the peak skin dose resulting from 
fluoroscopically guided interventions. Part I: Methods. J Appl Clin Med Phys 
2011;12:3670. 
53. Ying CK, Kandaiya S. Patient skin dose measurements during coronary 
interventional procedures using Gafchromic film. J Radiol Prot 2010;30:585–
96. 
54. Journy N, Sinno-Tellier S, Maccia C, Le Tertre A, Pirard P, Pages P, et al. 
Main clinical, therapeutic and technical factors related to patient’s maximum 
skin dose in interventional cardiology procedures. Br J Radiol 2012;85:433–
42. 
55. Giordano C, D’Ercole L, Gobbi R, Bocchiola M, Passerini F. Coronary 
angiography and percutaneous transluminal coronary angioplasty procedures: 
Evaluation of patients’ maximum skin dose using Gafchromic films and a 
comparison of local levels with reference levels proposed in the literature. 
Phys Med 2010;26:224–32. 
56. Satish C. Uniyal, Vineet Chaturvedi, Sunil D. Sharma and Anurag Rawat. 
PROCEDURES IN A DEDICATED CATHETERIZATION 
LABORATORY Radiation Protection Dosimetry (2017), Vol. 175, No. 2, pp. 
201–208. 
57. Koichi Chida, Mamoru Kato, Yohei Inaba, Ryota Kobayashi, Masaaki 
Nakamura, Yoshihisa Abe, Masayuki Zuguchi. Real-time patient radiation 
 
58 
dosimeter for use in interventional radiology.Physica Medica 32 (2016) 
1475–1478. 
58. Hansson B, Karambatsakidou A. Relationships between entrance skin dose, 
effective dose and dose area product for patients in diagnostic and 
interventional cardiac procedures.Radiat Prot Dosim 2000;90:141–4. 
59. Rana VK, Rudin S, Bednarek DR. Updates in the real-time Dose Tracking 
System (DTS) to improve the accuracy in calculating the radiation dose to the 
patients skin during fluoroscopic procedures. Proceedings of SPIE–the 
International Society for Optical Engineering; 2013; 8668:86683Z. 
60. Bordier C, Klausz R, Desponds L. Patient dose map indications on 
interventional X-ray systems and validation with Gafchromic XR-RV3 film. 
Radiat Prot Dosim 2015;163:306–18. 
61. Van Ngoc Ty C, Bonniaud G, Coulot J. Development of an analytical peak 
skin dose calculation tool in interventional radiology. Phys Med 
2014;30:e123–45. 
62. Attix FH. Introduction to Radiological Physics and Radiation Dosimetry 
[Internet]. Wiley; 1986. Available from: 
https://onlinelibrary.wiley.com/doi/book/10.1002/9783527617135 
63. Sandby-Møller J, Poulsen T, Wulf HC. Epidermal thickness at different body 
sites: relationship to age, gender, pigmentation, blood content, skin type and 
smoking habits. Acta Derm Venereol. 2003;83(6):410-3. 
64. Bacher K, Bogaert E, Lapere R, De Wolf D, Thierens H. Patient-specific dose 
and radiation risk estimation in pediatric cardiac catheterization. Circulation 
2005;111:83–9. 
65. Aly A. E, Duhaini I. M, Manaa S. M, Tarique S. M, Kuniyil S. E and Naemi 
H. M. A. Patient peak skin dose and dose area product from interventional 
cardiology procedures. Int. J. Med. Phys. Clin. Eng. Radiat. Oncol. 4, 7–12 
(2015). 
66. Saeed, M. K. Dose measurement using Gafchromic film for patients 
undergoing interventional cardiology procedures. Radiat. Prot. Dosim. 2016. 
(In press. doi: 10.1093/rpd/ncw082). 
67. Morrish, O. W. E. and Goldstone, K. E. An investigation into patient and 
staff doses from x-ray angiography during coronary interventional 
procedures. Br. J. Radiol. 81, 35–45 (2008). 
68. Balter S, Miller D. L, Vano E, Ortiz L. P, Bernardi G, Cotelo E, Faulkner K, 
Nowotny R, Padovani R and Ramirez A. A pilot study exploring the 
possibility of establishing guidance levels in x-ray directed interventional 
procedures. Med. Phys. 35, 673–680 (2008). 
 
 59 
69. Barnaoui S, Rehel J L, Baysson H, et al. Local reference levels and organ 
doses from pediatric cardiac interventional procedures. Pediatr Cardiol 
2014;35:1037-45. 
70. Harbron R W et al 2015 Radiation doses from fluoroscopically guided 
cardiac catheterization procedures in children and young adults in the United 
Kingdom: a multicentre study Br. J. Radiol. 88 20140852. 
71. Yakoumakis E, Kostopoulou H, Makri T, Dimitriadis A, Georgiou E, 
Tsalafoutas I. Estimation of radiation dose and risk to children undergoing 
cardiac catheterization for the treatment of a congenital heart disease using 
Monte Carlo simulations. Pediatr Radiol 2013; 43: 339–46. doi: https:// doi. 
org/ 10. 1007/ s00247- 012- 2510-3. 
72. Ubeda C, Miranda P, Vano E, Nocetti D, Manterola C. Organ and effective 
doses from paediatric interventional cardiology procedures in Chile. Phys 
Med. 2017 Aug;40:95-103. 
73. Tapiovaara M, Lakkisto M, Servomaa A. PCXMC: A Monte Carlo program 
for calculating patient doses in medical x-ray examinations (2nd Ed.). Report 
STUK-A231. Helsinki: Finnish Centre for Radiation Nuclear Safety; 2008. 
74. Servomaa A, Rannikko S, Nikitin V, et al. A topographically and 
anatomically unified phantom model for organ dose determination in 
radiation hygiene, STUK-A87. Helsinki: Finnish Center for Radiation and 
Nuclear Safety, 1989. 
75. Tapiovaara M, Lakkisto M, Servomaa A. PCXMC: A PC-based Monte Carlo 
program for calculating patient doses in medical x-ray examinations. 
Helsinki: Finnish Centre for Radiation and Nuclear Safety. Report STUK-
A139. 1997. 
76. Lee C, Lee C, Shah AP and Bolch WE. An assessment of bone marrow and 
bone endosteum dosimetry methods for photon sources. Phys. Med. Biol. 
2006b;51:5391–5407 
77. Cristy M, Eckerman KF. Specific absorbed fractions of energy at various 
ages from internal photon sources. I. Methods. Report ORNL/TM-8381/V1. 
Oak Ridge: Oak Ridge National Laboratory; 1987. 
78. Schmidt PWE, Dance DR, Skinner CL, Castellano Smith IA, McNeill JG. 
Conversion factors for the estimation of effective dose in paediatric cardiac 
angiography. Phys Med Biol 2000;45:3095–107. 
79. Omar A, Bujila R, Fransson A, Andreo P, Poludniowski G. A framework for 
organ dose estimation in X-ray angiography and interventional radiology 
based on dose-related data in DICOM structured reports. Phys Med Biol 
2016; 61: 3063–83. doi: https:// doi. org/ 10. 1088/ 0031- 9155/ 61/ 8/ 3063. 
 
60 
80. Beels L, Bacher K, De Wolf D, Werbrouck J, Thierens H. Gamma-H2Ax foci 
as a biomarker for patient X-ray exposure in pediatric cardiac catheterization: 
are we underestimating radiation risks? Circulation 2009; 120: 1903–9. doi: 
https:// doi. org/ 10. 1161/ CIRCULATIONAHA. 109. 880385 
81. Glatz AC, Patel A, Zhu X, Dori Y, Hanna BD, Gillespie MJ, et al. Patient 
radiation exposure in a modern, large-volume, pediatric cardiac 
catheterisation laboratory. Pediatr Cardiol 2014:1-9. 
82. Farah J, Trianni A, Ciraj-Bjelac O, et al. Characterization of XR-RV3 
GafChromic(®) films in standard laboratory and in clinical conditions and 
means to evaluate uncertainties and reduce errors. Med Phys. 
2015;42(7):4211-4226. doi:10.1118/1.4922132 
83. Borrego D, Lowe EM, Kitahara CM, Lee C. Assessment of PCXMC for 
patients with different body size in chest and abdominal x ray examinations: a 
Monte Carlo simulation study. Phys Med Biol. 2018 Mar 21;63(6):065015. 
doi: 10.1088/1361-6560/aab13e. PMID: 29465419; PMCID: PMC6376487 
84. Pelowitz DB. MCNPX Users Manual Version 2.7.0. 2011 
85. Johnson PB, Geyer A, Borrego D, Ficarrotta K, Johnson K, Bolch WE. The 
impact of anthropometric patient-phantom matching on organ dose: A hybrid 
phantom study for fluoroscopy guided interventions. Medical Physics. 
2011;38:1008–1017. 
86. McCabe BP, Speidel MA, Pike TL, Van Lysel MS. Calibration of 
GafChromic XR-RV3 radiochromic film for skin dose measurement using 
standardized x-ray spectra and a commercial flatbed scanner. Med Phys. 
2011;38(4):1919-1930. 
87. Morrell RE, Rogers A. Calibration of Kodak EDR2 film for patient skin dose 
assessment in cardiac catheterization procedures. Phys Med Biol. 
2004;49(24):5559-5570. 
88. Ying C.K., Kandaiya S. EDR2 Film for Skin Dose Measurement in Coronary 
Angiography. Sains Malaysiana 41(1)(2012): 133–140. 
89. Jarvinen, H. et al. Feasibility of setting up generic alert levels for maximum 
skin dose in fluoroscopically guided procedures. Phys. Med. 46, 67–74 
(2018). 
90. Jukka Järvinen, Joanna Sierpowska, Teemu Siiskonen, Minna Husso, Hannu 
Järvinen, Tuomas Kiviniemi, Tuomas T. Rissanen, Carita Lindholm, Hanna 
Matikka, Heli R. S. Larjava, Timo J. Mäkelä, Satu Strengell, Markku Eskola, 
Teuvo Parviainen, Elina Hallinen, Markku Pirinen, Antti Kivelä and Mika 
Teräs. CONTEMPORARY RADIATION DOSES IN INTERVENTIONAL 
CARDIOLOGY: A NATIONWIDE STUDY OF PATIENT SKIN DOSES 
 
 61 
IN FINLAND. Radiation Protection Dosimetry (2020), Vol. 188, No. 2, pp. 
181–190. 
91. M Pasquino, C Cutaia, M Poli, C Valero, G Peroni, M De Benedictis, E 
Petrucci, M Stasi. Patient's Peak Skin Dose evaluation using Gafchromic 
films in interventional cardiology procedures and its correlation with other 
dose indicators. Phys Med. 2018 Sep;53:103-107 
92. Kulkarni, A. R., Akhilesh, P. and Sharma, S. D. Measurement of patient skin 
dose and establishment of local diagnostic reference levels for interventional 
cardiology procedures. Radiat. Prot. Environ. 42(1), 28–33 (2019). 
93. Krajinović M, Dobrić M, Ciraj-Bjelac O. SKIN DOSE MAPPING IN 
INTERVENTIONAL CARDIOLOGY: A PRACTICAL SOLUTION Radiat 
Prot Dospimetry. 2020 Jul 2;188(4):508-515. 
94. Françoise Malchair, Jérémie Dabin, Marine Deleu, Marta Sans Merce, 
Olivera Ciraj Bjelac, Aoife Gallagher, Carlo Maccia, Review of skin dose 
calculation software in interventional cardiology. Physica Medica 
2020;80:75-83. 
95. Brambilla M, Cannillo B, Matheoud R, Compagnone G, Rognoni A, Bongo 
AS, et al. Conversion factors of effective and equivalent organ doses with the 
air kerma area product in patients undergoing coronary angiography and 
percutaneous coronary interventions. Phys Med. 2017;42:189–96. 
96. Rassow J, Schmaltz AA, Hentrich F, Streffer C. Effective doses to patients 
from pediatric cardiac catheterization. Br J Radiol 2000;73:172–83. 
97. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, et al. 
Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. 
Radiat Res 1994; 137(2 Suppl): S17–67. doi: https:// doi. org/ 10. 2307/ 
3578892 
98. Harbron RW, Chapple C-L, O'Sullivan JJ, Best KE, Berrington de Gonzalez 
A, Pearce MS. Survival adjusted cancer risks attributable to radiation 
exposure from cardiac catheterisations in children. Heart 2017; 103: 341–6. 
doi: https:// doi. org/ 10. 1136/ heartjnl- 2016- 309773 
99. Cristy M. Active bone marrow distribution as a function of age in humans. 
Phys. Med. Biol., 1981, Vol. 26. No. 3, 389-400 
 
 
